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INTRODUCTION 
Viruses play an extremely important role in the direct causation of 
disease by interacting with host cells through an extreme variation of 
pathogenic mechanisms ranging from cytolytic effects to integration of 
viral genomes with the host's genetic material. The virus-host cell 
interaction can also result in other disease processes in which the virus 
seems to play an indirect role. The interaction of viruses with the 
cells, tissues and humoral products of the imnune system constitute the 
most important of these indirect effects, manifested through inhibition of 
iimune responses or indirect tissue damage by antiviral immune mechanisms. 
The immunosuppressive potential of viral infection has been recog­
nized for over half a century but only in the last 10 or 15 years has it 
been the subject of intensive investigation. A variety of viruses be­
longing to several groups and including both oncogenic and nononcogenic 
viruses have been shown to be immunosuppressive. Ability to infect and 
alter the cells of the immune system is perhaps the common denominator of 
most of these immunosuppressive viruses. 
Bovine viral diarrhea (BVD) virus has been the subject of appreciable 
investigation at Iowa State University and elsewhere. The nature of the 
disease produced and the pathogenesis of the infection have been investi­
gated, but the virus-host interrelationships concerned with immunologic 
processes have not received concerted study. The virus elicits a marked 
effect upon lymphoid tissues. Field observation of post-vaccinal reac­
tions (Peter et al., 1967) as well as studies on vir/us-lymphoid cell 
interaction in vitro (Truicc and ShéciiïnèlstÊr, 1973; "liscoplatt st &1., 
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1973a) have suggested the possibility of immunodepression during infec­
tion, but detailed studies on the BVD virus-host irrenune system interac­
tions have not been reported. 
This study was designed to determine if immunosuppression results 
from BVD infection and, if so, how it would affect the recovery from a 
concurrent viral infection. Infectious bovine rhinotracheitis (IBR) virus 
was selected to measure this effect, since it is frequently associated 
with BVD virus in disease conditions of feedlot cattle. Combined BVD-IBR 
infections are a common finding when groups of cattle from different 
origins are assembled in feeder operations in Iowa and elsewhere, usually 
resulting in severe economic losses. Enhanced IBR virus multiplication, 
often with generalized infection, is a finding cotmon to both natural 
outbreaks and postvaccinal reactions. If infection with BVD virus inter­
feres with resistance to IBR virus infection, the severity of the clinical 
disease could be significantly enhanced. 
The objectives of the experimentation reported in this dissertation 
were: (1) to study the normal process of recovery from IBR and BVD virus 
infections by analyzing the specific and nonspecific immunologic re­
sponses, with emphasis on cellular immunity; and (2) the effect of con­
current BVD virus infection on the process of recovery from IBR virus 
infection. 
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REVIEW OF LITERATURE 
Resistance to Viral Infection 
The defense mechanisms that enable man and animals to resist a viral 
infection, or to recover from it, comprise both specific and nonspecific 
factors. The nonspecific mechanisms, usually active against a variety of 
viruses, constitute what Raffel (1961) termed "native immunity", and are 
for the most part a genetic property of an animal species. The specific 
inrnune mechanisms, on the contrary, are more of an individual property. 
They are dependent upon the individual's exposure to a particular antigen 
and, on a purely mechanistic basis, the types of responses tend to spread 
through broad evolutionary steps rather than being confined to particular 
animal species. 
Nonspecific factors 
The obligatory intracellular nature of parasitism by viruses requires 
the presence of susceptible tissues in an animal for virus multiplication 
tc t2K2 place. The absence c-f ^"rn hissu^s, confers a ccndition of total 
resistance to the particular agent irrespective of infectious dose or 
general resistance of ths host to infectious diseases (Smorodintsev, 
1960). However, even potentially pathogenic viruses can fail to gain 
entrance into the organism or, even if initial virus replication takes 
place, the host can achieve extinction of the agent by the role of a 
series of nonspecific factors. 
Epithelial surfaces — the skin and mucous membranes The epithe­
lial surfaces provided by the skin and mucous membranes offer a physical 
barrier to penetration by viruses. In addition to this passive effect, 
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lactic acid, fatty acids and lysozyme present in sweat and sebaceous se­
cretions confer bactericidal and viricidal properties (Raffel, 1961). 
Similar factors exist in the moist mucous films of the respiratory and 
genital mucosas, and also in the saliva and gastrointestinal secretions 
where pH changes and strong enzymatic activity offer added protection. 
The indigenous microbial flora, particularly at the level of the 
gastrointestinal tract plays a very important role in host resistance to 
infectious diseases (Abrams. 1970). Physiological and morphological 
parameters of the small intestine with particular reference to enzymatic 
activity, intestinal absorption, epithelial cell renewal and lymphoid 
development, have been shown to be directly related to the presence of 
intestinal flora as. observed in comparison of conventional and germ free 
animals. 
The ciliary movement of the respiratory epithelium is very effective 
in cleaning mucus and particulate materials from the airways and is prob­
ably an important factor in resistance to respiratory infections. How­
ever, airborne viruses c?n nrnhflnly rmAch t.liè lower respiratory tract by= 
passing the clearance mechanism, when sufficiently small particles are 
present in a viral aerosol (Knight, 1973). In addition, viruses such as 
influenza and parainfluenza in man have been shown to have specific af­
finity for cilia, attaching firmly to them and possibly contributing to 
cell infection (Tyrrell, 1973). 
Virus neutralizing factors in blood and body tissues A number of 
substances in normal serum, body fluids and tissues are capable of neu­
tralizing a wide range of viruses, and are very likely to be of signifi­
cance in the host resistance to viral infections. The bactericidal 
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enzyme, lysozyme, recognized by Fleming in 1922, occurs in tissues and 
several body fluids (Raffsi, 1961). Its antiviral activity was recognized 
by Ferrari et al. (1959). A variety of thermolabile, nonspecific inhib­
itors are found in the serum and tissues of man and a variety of warm 
blooded animals (Raffel, 1961; Smorodintsev, 1960; Nash et al., 1971). 
They can inhibit the infective or hemagglutinating activity of a wide 
range of viruses, including all the myxoviruses, many arboviruses, adeno­
viruses and enteroviruses (Ginsberg and Horsfall, 1949; Porterfield and 
Rowe, 1960). Many of these inhibitors seem to be lipidic in nature 
(Smorodintsev, 1960; Porterfield and Rowe, 1960; Salminen, 1362; 
Sanderson, 1968; Bidwell and Mills, 1968). Phosphatase enzymes of tissues 
have been shown to neutralize herpes simplex virus (Amos, 1953). 
A complement-requiring plasma protein possessing bactericidal proper­
ties, properdin, was described by Pillemer et al. in 1954. Ginsberg and 
Wedgwood (1960) ascribed virus neutralizing properties to this protein, 
with action on Newcastle, influenza, T-bacteriophages and other viruses. 
Although thc:c proteins v.'sre disn^issed by ni?.ny ?? n^furHi rtnf.inoiilHs it 
has been shown recently (Pensky et al., 1968) that it is indeed a unique 
serum protein, nonimmunoglobulin in character, with the capability of 
cleaving the C3 complement fraction (alternative pathway for complement 
activation) (Lepow, 1971). 
Body temperature Smorodintsev's experiments (reviewed by 
Smorodintsev, 1960) showed that a number of animal viruses such as in­
fluenza, Japanese encephalitis, ectromelia and vaccinia are inactivated at 
normal body temperatures. Observations that an increase in body tempera­
ture usually results in faster rates of inactivation of the virus or 
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increased survival of susceptible animals, are far more significant from 
the standpoint of resistance to infection since they imply that febrile 
responses can be a major factor in the recovery process. Smorodintsev 
(1960) reported that increases of body temperature of both susceptible and 
insusceptible animals resulted in a faster rate of inactivation of in­
fluenza virus. Walker and Boring (1958) observed that the multiplication 
of Coxsackie virus and its pathogenicity for mice depended upon body 
temperatures; artificially lowered temperatures resulted in increased 
lethality, increased temperatures resulted in failure of virus multiplica­
tion and complete survival. Similar results were reported by Lwoff (1959) 
with poliovirus in mice. 
The preceding observations suggest that fever can be an important 
factor in resistance of the host to the spread of viruses in the organism. 
The mechanism of action is unknown, however, and, since fever results in 
many secondary changes in metabolic activity, it is possible that the in­
creased temperature per se is not the main factor in viral inactivation. 
Lwuff (1953) has l,ypùuucsizcd tliat the high temperature result: In release 
of lysosomal nucleases responsible for destruction of viral RNA during 
virus replication. 
Inflammatory reaction Although there is no doubt about the value 
of local inflammation in the native defense of the host during bacterial 
infections, it may be of lesser importance in resistance to viral infec­
tions. The inflammation that accompanies viral infections is usually 
secondary to the primary cellular alterations and the polymorphonuclear 
response is usually lacking (Bruner and Gillespie, 1973). Nonetheless, 
the increase in temperature, localized acidity, decreased oxygen tension, 
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changes in osmolarity and salt concentration, and local exudation, could 
be factors in inactivation or localization of many viruses (Baron, 1973). 
Phagocytosis Although phagocytic cells constitute a very im­
portant factor among the defense mechanisms of the body due to their 
ability to ingest and dispose of foreign material, their role in viral 
infections is highly variable. Virus particles can be taken up by phago­
cytes in the same manner as nonviral particles. Blood clearance studies 
of viral particles in mice have shown that the rate of clearance depends 
largely on the size of the particles. Small viruses such as T7 bacterio­
phage and Rift Valley fever virus are taken up much more slowly than 
larger viruses such as vesicular stomatitis virus or vaccinia virus 
(Mims, 1964). 
Phagocytosis of a virus by macrophages does not necessarily imply an 
effective defense mechanism. Viruses such as vaccinia, influenza and 
myxoma in the mouse, aid ectromelia in the rat, are cleared by liver 
macrophages, digested and degraded. Other viruses such as distemper virus 
in tluyb, yellow fcVci" virus in mcr.kcys sr.ci cctrcmslia in the mouse; r*,, 
replicate in macrophages and later spread to other susceptible cells. 
These observations suggest that, at least in some cases, the final outcome 
of an infection could largely depend on the initial virus-macrophage 
interactions (Mims, 1964). 
Available Information strongly Indicates that resistance to some 
virus infections is expressed through macrophages. Although both adult 
and suckling mice are susceptible to encephalitis induced by intracerebral 
Inoculation of herpes simplex virus, only suckling mice develop encepha­
litis after peripheral inoculation. Johnson (1964a) observed that the 
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initial replication of herpes simplex virus after extraneural inoculation 
of suckling mice takes place in macrophages including subcutaneous or 
submucosal histiocytes, alveolar macrophages or peritoneal macrophages de­
pending upon the route of inoculation. The virus later spreads to other 
tissues and to the CNS via neural or hematogenous routes. In contrast, 
the infection is arrested at the macrophage level in adult mice. In vitro 
experiments have shown that although the virus replicates equally well in 
macrophages from suckling or adult mice, the latter have the ability to 
restrict its spread to contiguous cells (Johnson, 1964b). The mechanism 
of this action has not been described. Similar observations were reported 
by Gal lily et al. (1967) with mouse hepatitis virus and macrophages from 
CH3 mice. Genetic resistance of some strains of mice to many arboviruses 
is also related to the ability of macrophages to destroy the virus 
(Goodman and Koprowsky, 1962a,b; Olson et al., 1975). 
The cited examples stress the possible significance of the macrophage 
in natural resistance to viral infections, but macrophages also play a 
very impur târiL rolè 1,1 Specifically Gcquirsd iïïr.ur,ity. In addition to 
their purely phagocytic and virus destroying properties, their participa­
tion in the early stages of the immune response can be subject to genetic 
variation. In this regard, Belgrade and Osborn (1974) have reported that 
in strains of mice with different degrees of susceptibility to murine 
cytomegalovirus infection, the difference in susceptibility can, to a 
certain degree, be due to differences in macrophage function during the 
inductive phase of the iimune response. 
Interferon Interferon was first described by Isaacs and Lindenmann 
(1957) as a cell protein, produced in response to viral infection, with 
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the property of conferring on cells resistance to the multiplication of 
viruses. A modern definition would be: "Interferons are cell coded pro­
teins induced by foreign nucleic acids; they are nontoxic for cells but 
are able to inhibit the multiplication of vertebrate viruses in cells of 
homologous species" (Fenner et al., 1974). 
Interferon is today considered a family of proteins since their 
molecular weights vary considerably depending upon the source. The range 
varies from 28,000 to 160,000 (Friedman and Sonnabend, 1970). All the 
interferons so far examined are nondialyzable, not sedimented by centri-
fugation at 100,000 g for 4 hrs, susceptible to proteolytic enzymes, and 
are stable over a wide pH range (2 to 10). A possible exception to this 
pH resistance is the interferon produced in leukocytes in response to 
phytohemagglutinin (Wheelock, 1965), which was stable at pH 3-9 but not at 
pH 2 or 10. 
In an appropriate host, virtually all animal viruses induce formation 
of interferon. Double stranded RNA (viral RNA, replicative intermediates, 
or suiiie uuuule buatiuêu RNA Cùniplcxes observed during normal transcription 
of DNA viruses) seems to be the inducer molecule (Colby and Morgan, 1971). 
The mechanisms of interferon induction and action are still largely 
unknown, A derepression hypothesis of interferon synthesis (Burke, 1966) 
is widely accepted but has not been proven. It suggests derepression of 
the cell genome by the viral inducer resulting in synthesis of interferon 
and any other proteins involved in its production. According to Marcus 
and Salb (1966) interferon would then act on other cells by inducing the 
synthesis of a cell coded "translation inhibitory protein". This protein 
would bind to and modify the ribosomes capacity to translate viral RNA. 
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These specific defects in the function of ribosomes were not confirmed 
however in the detailed analysis of Kerr et al. (1970). Recent evidence 
implicates transcription of viral RNA as the basic defect in the viral 
replication mechanism (Bialy and Colby, 1972). 
Whatever its mechanism of action, interferon produced by one cell 
type is active against a wide variety of viruses although the sensitivity 
of different viruses varies markedly (Stewart et al., 1969). Interferon 
has a high degree of host-cell species specificity although it shows no 
evidence of organ or tissue specificity (Fermer et al., 1974). 
Specifically acquired immunity 
The specific immune responses are concerned with recognition of the 
foreign nature of sustances, microorganisms or cells introduced into the 
body, and the subsequent reaction of the host toward these foreign ma­
terials. This reaction encompasses a series of cellular interactions ex­
pressed by the elaboration of specific cell products and by specific cell 
changes in morphology, function or both. Bellanti (1972) established 
these yerier-dl uharàuLet isl'ics ûf the specific iiTuT.LiriS response v;h1ch dis­
tinguishes it from the nonspecific response; (1) specificity of the re­
actions toward the inducing agents; (2) heterogeneity of the cell types 
and cell products involved and their mechanisms of action; and (3) memory ; 
a property which results in augmentation of the response through prolifer­
ation and differentiation of cells upon subsequent exposure to the origi­
nal inducer. 
There are two general types of effector mechanisms which mediate 
specifically acquired immunity, those mediated by cell products of the 
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lymphoid tissues (antibodies, humoral immunity) and those mediated by 
lymphocytes with or without cooperation of other cell types (cell-mediated 
immunity). 
These effector mechanisms evolve from two functionally different 
lymphoid systems, one developing under thymic influence and another de­
veloping under an alternative influence which has been precisely located 
only in birds in the bursa of Fabricius. The concept of these dual iimmu­
nity systems evolved from tissue extirpation experiments and clinical 
observations. Glick et al. (1956) observed that removal of the bursa of 
Fabricius from newly hatched chickens resulted in impaired capacity to 
produce antibodies. Aspinall et al. (1963) reported retarded homograft 
rejection in chickens after neonatal thymectomy. Cooper et al. (1966} 
provided definitive evidence for a dichotomous immune system in chickens, 
in which the bursa of Fabricius controlled antibody formation and the 
thymus cell-mediated reactions. 
Similar observations were reported in rodents (Good et al., 1962) 
where thymectomy also resulted in impaired cell-mediated iimiune reatliuny 
and lymphopenia. Lymphocyte depletion resulted only in certain areas of 
the lymphoid tissues (thymus-dspendent areas), while follicles, germinal 
centers and plasma cells are unaffected (Waksman et al., 1962). A series 
of clinical observations in man by Good and his colleagues (reviewed by 
Good et al., 1971) on immune deficiency diseases such as Burton agairana-
globulinemia, Di George's syndrome, thymomas and myelomas, further con­
firmed the existence of a dual immune system in mammals. However, the 
mammalian equivalent of the bursa of Fabricius has not been definitely 
identified. 
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The functionally distinct lymphocytes were designated "T" cells (for 
thymus-derived or thymus-dependent) and "B" cells (for bursa or bursa-
equivalent-derived). These two cell types possess differential charac­
teristics such as presence or absence of surface immunoglobulins, antigens 
or receptors, tissue distribution, function, response to mitogens and 
susceptibility to X-irradiation, corticosteroids or antilymphocyte serum 
(Greaves et al., 1973). They are not homogeneous populations, however, 
and functional subpopulations have been described (Greaves et al., 1973). 
It must be emphasized that the functional separation of T and B cells 
is not absolute, and that cell interactions (lymphocyte-lymphocyte and 
macrophage-lymphocyte) are very important at all stages of immune re­
sponses. Greaves et al. (1973) have reviewed lymphocyte-lymphocyte inter­
actions and divided them into three general categories: 
(1) B-B and B-T interactions -- B cells can influence the response of 
other B cells through the action of antibody, and "feedback" regulation of 
antibody response by antibody was demonstrated in several systems (re­
viewed by Uhr and moller, 1966). Likewise, antibody can ir.fluSr.cc T call 
responses. Kaliss (1959) reported enhancement of tumour growth by passive 
antibody, and Axelrad (1958) reported partial inhibition of delayed hyper­
sensitivity to sheep red blood cells in rats by passively injected anti­
body. Conversely, Liew and Parish (1972) reported suppression of antibody 
responses to flagellin and sheep erythrocytes in rats by passive antibody, 
with accompanying enhanced cell-mediated immunity. 
(2) T-B cell cooperation — The existence of T-B cell interaction in 
antibody production has been demonstrated beyond any doubt in many ex­
perimental systems and for a variety of antigens (reviewed by Greaves 
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et al., 1973). After the original observation of Ovary and Benacerraff 
(1963) that secondary responses to hapten-carrier complexes was only 
possible if the same carrier was used in both inoculations, continued 
work on the subject finally led to the conclusion that T cells collaborate 
in the immune response by recognizing "helper" determinants in the car­
rier molecule, somehow "helping" B cells to make antibody to the haptenic 
antigenic determinants (Rajewsky et al., 1969). The nature of the inter­
action is still obscure. It could involve (a) antigen bridges (Mitchison 
et al., 1970) between T and B cells or T cells, B cells and macrophages; 
(b) release of short range factors by T cells (active on B cells or B 
cells and macrophages) either antigen specific (Feldmann et al., 1973) or 
nonspecific (Button et al., 1971); or (c) a combination of both. 
(3) T-T cell cooperation — Different T cell subpopulations may 
cooperate in graft-versus host responses as described by Cantor and 
Asofsky (1972) but the nature of those interations is still unclear. 
Macrophage-lymphocyte interactions are also very important in both 
inductive ana effector stages of specific iiiiiiiuiic respGnses (Gottlieb and 
Waldman, 1972; Nossal and Ada, 1971; Unanue, 1972; Schwartz et al., 1970). 
Macrophage-depleted lymphocyte cultures give only a weak proliferative 
response to soluble antigens or allogeneic cells (Oppenheim et al., 1968) 
and marginal or negative antibody responses to most antigens (Feldmann, 
1972). Macrophage-bound antigen constitutes a very effective trigger for 
both T and B lymphocytes (Katz and Unanue, 1973). After antigens are 
broken down by macrophages a persistent fraction is found on the cell 
membrane (Unanue and Cerottinij 1970). These cell surface associated 
antigens are probably essential for the macrophage-lymphocyte interactions 
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in the induction of the immune response, considered to be a surface 
phenomenon involving antigen presentation (Unanue, 1972). Macrophages act 
nonspecifically (Greaves et al., 1973) and they display a high level of 
activity, even when present at very low concentration (under 1%) in a 
given population (Rosenstreich and Rosenthal, 1974). 
Humoral antibody response to viral infections The replication of 
viruses in the host produces several different antigens. Some are struc­
tural components, but many of them are virus induced enzymes. In poxvirus 
infected cells, less than one-half of the antigens detected are incorpo­
rated into the virions. Probably only a few of the antibodies which react 
with these viral antigens play a significant role in protection (Fenner 
et al., 1974). 
Five main classes of immunoglobulins have been identified in man: 
IgG, IgM, IgA, IgD and IgE (Syîêgelberg, 1974). Of these, at least three 
(IgG, IgM and IgA) contain antiviral antibody activity (Bellanti and 
Svehag, 1971). These three immunoglobulins constitute by far the bulk of 
the immunoglobulin prebenL in liuman seriiir. with the ccrr.bir.ed average con­
centration about 18 mg/ml compared to 0.03 mg/ml for IgD and IgE combined 
(Spiegelberg, 1974). IgM and IgG (îgGi and IgG, and somewhat less IgG?) 
can fix complement. IgA can fix complement only by the alternate or by­
pass mechanism. IgG (IgGi and IgGg) can bind to macrophages (Spiegelberg, 
1974). 
Analogs of three of those classes (IgG, IgM and IgA) have been 
identified in the bovine species (Porter, 1973; Butler, 1973). Homo-
cytotropic antibody has also been reported in what apparently is a dis­
tinctly new immunoglobulin class (Hammer et si., 1971). The IgG^ subclass 
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of bovine IgG fixes complement (Porter, 1973), but the bovine IgM is a 
weak complement fixer (Rice, 1968). At least the IgG and IgM classes of 
serum antibody display antiviral activity (Cowan and Wagner, 1971). 
In general, IgM antibodies appear earlier in the serum than IgG 
antibodies (Rice, 1968). This sequential appearance of the different 
classes of antibodies has been observed both after natural viral infection 
or inoculation with live vaccinal strains (Ogra et al., 1958; Bellanti and 
Artenstein, 1954), and after parenteral inoculation of nonreplieating 
viral antigens (Svehag and Mandel, 1964a,b; Svehag, 1964a,b; Webster, 
1965, 1968a,b). Webster's experiin^nts, utilizing influenza virus antigens 
in rabbits, showed that the IgM antibodies were of high avidity and with 
high cross reactivity while the initial IgG response was of low avidity 
and greater specificity. The avidity of these IgG antibodies increased 
with time. 
The basis for inhibition of virus infectivity due to neutralization 
by antibody has not been adequately established. It has been shown re­
peatedly InàL viruses are not rendered Irrsvsrsib'.y noninfectinus hy 
neutralizing antibody (Mandel, 1971). Early views of the neutralization 
phenomenon considered antibody as inhibiting attachment of virus to the 
cell and preventing engulfment of attached virions (razekas de St. Groth, 
1962). However, there is now evidence to the contrary. Smith et al. 
(1961) found that although antiserum to vaccinia virus reduced plaque 
formation in L cells 100%, 20% of the particles were attached to the cells 
but still failed to initiate infection. Dales and Kajioka (1964) reported 
that vaccinia virus coated by antibody was still able to attach to L 
cells, and eventually be engulfed. However s antibody reduced the number 
of cell-associated virions, blocked the release of virus from phagocytic 
vesicles and rendered the virus susceptible to degradation within the 
vesicle. Silverstein and Marcus (1964) reported similar results for 
Newcastle disease virus. 
Mandel (1967a,b) found that most of neutralized poliovirus attached 
strongly to HeLa cells, but its viral RNA was completely degraded by the 
cells. The finding led to the suggestion that antibody brings about a 
change in the normal mode of attachment of poliovirus with the viral 
particles being actively phagocytized and brought into contact with 
lysosomes. 
It should be emphasized that the neutralization process and its 
efficiency not only depends on the antibody, but also on the particular 
cells used as an indicator (Lafferty, 1965). While chicken antibody 
actually enhanced the infectivity of flaviviruses for chick embryo fibro­
blasts, it neutralized their infectivity for heterologous cells (Hawkes 
and Lafferty, 1967). 
ihs prcccss of virus neutralization is nmhanly nmrA effective in 
vivo due to the action of complement. Berry and Almeida (1968) showed 
that avian bronchitis virus is actually destroyed by complement after re­
action with antibody in a mechanism resembling the lysis of erythrocytes 
by IgM antibody and complement. Complement greatly enhances the neutral­
izing capacity of IgM and early IgG antibody, although it usually does not 
affect late IgG antibody (Hampar et al., 1968; Potgieter, 1974). Early 
whole antiserum is also dependent on complement for optimal neutralization 
(Yoshino and Taniguchi, 1969; Potgieter, 1974). 
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The mechanism of action of complement is not well understood. Wallis 
and Mel nick (1971) proposed that early antibodies are monovalent and fail 
to aggregate the virus without complement. Complement would produce 
immunoaggregation. The reason for the difference between early end late 
IgG antibodies in complement dependency probably lies in their differences 
in specificity, affinity, valence and configuration (Blank et al., 1972). 
Still another possible mechanism of antiviral activity under in vivo 
circumstances is the promotion of phagocytosis by opsonizing antibodies 
(Mims, 1964). 
Cell-mediated immune response to viral infections There is now 
abundant evidence that viruses elicit cell-mediated iiraiunity. Initial 
interest in this field was derived mainly from clinical observations in 
man, where a number of conditions were associated with enhanced suscepti­
bility to viral infections (Glasgow, 1970; Allison and Burns, 1971). The 
common denominator of these conditions was impairment of at least one 
component of the immune response, and particularly, thymic deficiency. 
Patients wiLh uncomplicated ssvsrc hypogsirr^gicbiillp.eir^ia rcccvcrcdrorzsTly 
from measles, varicella, or small pox vaccination. However, in patients 
with congenital abnormalities predominantly affecting cell-mediated immu­
nity such as ataxia-telangiectasia, Swiss-type agammaglobulinemia, and the 
syndromes of Wiskott-Aldrich, Gitlin, Nezelof and Di George, virus in­
fections were a recurring problem. Cancer chemotherapy, immunosuppressive 
therapy after tissue transplants, and Hodgkin's disease, which also de­
press cell-mediated immunity, result in increased susceptibility to viral 
infection. Cytomegalovirus, herpes simplex, varicella and vaccinia 
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viruses are some of the most common agents involved (World Health Organi­
zation, 1973). 
The preceding observations were paralleled by experimental infections 
in which host resistance had been altered by various immunosuppressive 
regimens. Glasgow (1970), Allison (1972b) and North (1974) have reviewed 
some of this work. The general observation has been of increased suscep­
tibility in laboratory animals to viruses such as herpes simplex, ectro-
melia, vaccinia or oncogenic viruses such as polyoma or leukemia viruses 
after treatments principally affecting cell-mediated immunity (thymectomy, 
antilymphocyte serum). 
A common pattern has emerged from both clinical and experimental 
work; viruses which can express viral antigens in the host's cell membrane 
(i.e., poxviruses, herpesviruses, oncogenic viruses) elicit cell-mediated 
immune responses, and these responses seem to be essential for host re­
sistance. "with virus infections where plasma viremia is the rule and cell 
membrane modifications are not prominent (i.e., enteroviruses, toga-
viruses), cell-rued id Leu iiimiuii i ty is usually "Gt elicitsd and circulating 
antibody seems to play a preponderant role in host resistance to infection 
(World Health Organization, 1973; Allison; 1971), 
For years, the skin delayed hypersensitivity reaction was the only 
method of testing for cell-mediated immune responses in the live animal. 
But histological studies of the skin reactions and the passive transfer 
of dermal reactivity with lymphoid cells, resulted in the identification 
of the specifically sensitized lymphocyte as the cell responsible for this 
reaction. Subsequently, the study of the interactions in vitro between 
antigens and sensitized lymphocytes, and the apparent correlation between 
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some of these interactions and the condition of delayed hypersensitivity, 
led to the establishment of a series of in vitro correlates of cell-
mediated immunity. These correlates have been extensively detailed or 
reviewed by Lawrence and Landy (1969), Bloom and Glade (1971), Revillard 
(1971), World Health Organization (1973) and McCluskey and Cohen (1974). 
Therefore, consideration of this subject will be limited with emphasis on 
those mechanisms and applications that relate more directly to the ex­
perimentation described in this dissertation. 
Lymphocyte stimulation Lymphocytes cultured in vitro and 
exposed to a variety of stimulants respond with morphological enlargement 
to large lymphoblasts (large cells having a basophilic cytoplasma and one 
or more nucleoli) and by cell proliferation (Robbins, 1964; Oppenheim, 
1968; Valentine, 1971). This cell proliferation and transformation can be 
quantitated by lymphoblast counts in stained preparations, or much more 
accurately by the measure of tritiated thymidine uptake, an indicator of 
total ONA synthesis, or uptake of radioactive aminoacids, an indicator of 
• • ' I • r % t  .  r \ t  I .  _  jjr uueni bytii-neb ib aiiu vuiicii, is/t/. 
Lymphocytes can be stimulated by specific antigens or by nonspecific 
stimulants which do not need prior sensitization of cell donors to be 
effective (Oppenheim, 1968). Phytohemagglutinin (PHA), pokeweed mitogen 
(PWM), concanavalin A (Con A) and bacterial lipopolysaccharides (LPS) are 
among the most widely employed nonspecific stimulants (Hirschhorn and 
Hirschhorn, 1974). PHA and Con A stimulate T cells in man and mouse 
(Janossy and Greaves, 1971; Anderson et al., 1972; Mellstedt, 1975). PWM 
stimulates both T and B lymphocytes (Douglas, 1972; Janossy and Greaves, 
1972) at the usual concentration, although at low concentration it seems 
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to stimulate B cells only (Ivanyi and Lehner, 1974). LPS is a B cell 
stimulant (Ivanyi and Lehner, 1974; Peavy et al., 1974). A somewhat 
different group of nonspecific stimulants would include anti-gammaglobu-
lin, selectively stimulating B cells, which bear immunoglobulin receptors 
(Hirschhorn and Hirschhorn, 1974). 
The specific-antigen stimulants require previous lymphocyte sensiti­
zation of the donor. The stimulation thus constitutes a specific iirsnune 
response. This implies a recognition step by specific receptors on 
lymphocyte membranes. While B lymphocytes have detectable membrane 
immunoglobulin receptors that are capable of binding the antigen for 
which the cell is specific (Davie and Paul, 1971; Davie et al., 1971), 
there is no agreement on the nature of the receptors on T lymphocytes. 
Some workers detected immunoglobulins on the membrane of T lymphocytes 
(Marchalonis et al., 1972; Hammering and Rajewsky, 1971) whereas other 
workers have failed to do so (Vitetta et al., 1972; Perkins et al., 1972). 
Waldron et al. (1973) clearly demonstrated the requirement for macro­
phages for the in vitro stimulation of sensitized guinea pig lymphocytes 
by PPD. They concluded that macrophages play an obligatory role in the 
proliferative response to specific mitogens (Waldron et al.. 1973; 
Waldron et al., 1974). A number of other workers have reported this need 
for an interaction between macrophages and T lymphocytes for optimal 
stimulation of lymphocytes by antigen (Cline and Swett, 1968; Hersh and 
Harris, 1968; Seegh and Oppenheim, 1970; Cohen and Paul, 1974; Lipsky and 
Rosenthal, 1975). Cytophilic antibody on the surface of the macrophage is 
a possible mechanism for mediating the reaction by contributing to antigen 
binding (Cohen et al., 1973; Cohen and Paul, 1974). However, Rosenthal 
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and Shevach's observation (1973) that identity between histocompatibility 
antigens of macrophages and lymphocytes is necessary for antigen presenta­
tion suggests a more complex system than simply antigen specific immuno­
globulin receptors on the effector cells. 
A third category of stimulants that does not really fit either of 
the preceding classes includes the allogeneic lymphocytes and the anti-
allotypic antibodies. Cocultivation of lymphocytes (mixed lymphocyte 
culture) from genetically unrelated individuals results in cross stimula­
tion, referred to as the mixed lymphocyte response (MLR). This reaction 
resembles nonspecific stimulation in that there is no need for prior 
sensitization, but it also resembles specific stimulation because recog­
nition of antigenic difference is involved (Hirschhorn and Hirschhorn, 
1974). 
The nonspecific stimulants find clinical application in evaluation of 
lymphocyte reactivity for diagnosis of immunodeficiency diseases (con­
genital or acquired) or for evaluation of immunosuppressive treatments. 
They also have been extensively used in experimetiLaLioii fw, devclcpmsr.t 
and evaluation of immunosuppressive drugs, studies on immunomanipulation 
and study of the pathogenesis of some viral diseases (Revillard-, 1971). 
Specific stimulation of lymphocytes by viral antigens has been used 
in a number of viral diseases to evaluate cell-mediated iiraiune responses. 
Included in these studies are the following: herpes simplex virus 
(Rosenberg et al., 1972; Wilton et al., 1972; Starr et al., 1975); vari-
cella-zoster virus (Jordan and Merigan, 1974); vaccinia virus (Rosenberg 
et al., 1972; Elves et al., 1953); rubella virus (Lee and Sigel, 1974; 
Morag et al., 1974); measles virus (Graziano et al., 1975); Sindbis virus 
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(Griffin and Johnson, 1973); mumps virus (Smith et al., 1972); Epstein-
Barr virus (Gerber and Lucas, 1972); rabies virus (Wiktor et al,, 1974; 
Hill, 1974) and infectious bovine rhinotracheitis (Davies and Carmichael, 
1973; Rouse and Babiuk, 1974a). In most of the studies there was evidence 
that the period of lymphocyte reactivity is short-lived; reactivity is 
first detected 3-5 days after inoculation, usually peaks at approximately 
1 week post inoculation and drops to or near background levels in 2-3 
weeks post inoculation (Rosenberg et al., 1972; Griffin and Johnson, 1973; 
Davies and Carmichael, 1973; Rouse and Babiuk, 1974a; Hill, 1974). The 
degree of stimulation can be enhanced by purificati i of the virus prep­
arations, although relatively crude viral antigens usually provide satis­
factory stimulation (Rosenberg et al., 1972). Inactivated virus should be 
used as the source of viral antigen, especially for those viruses able to 
multiply in macrophages or lymphocytes, since viral multiplication can 
result in depression of cell metabolism (Rosenberg et al., 1972). 
Cytotoxic reactions Cytotoxic effects of lymphocytes on 
adjacent cells were first clearly ubberveu iii Iristological secticr.s of 
tumors undergoing immunological rejection and subsequently recognized in 
allografts of normal tissues, in contact allergy and in a variety of 
experimental autoallergic lesions (Waksman, 1974). 
A variety of experimental techniques have been developed to charac­
terize the cytotoxic reaction and describe the mechanisms of target cell 
destruction. Several distinct types of in vitro cytotoxic mechanisms have 
been recognized (Perlmann and Holm, 1969; Waksman, 1974); 
(1) Direct cytotoxic effect on target cells by lymphocytes from 
sensitized donors -- These reactions require adherence of the sensitized 
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lymphocytes to the target cells, an immunologically specific event, while 
the subsequent target cell effects are nonspecific (Wilson, 1965a,b). 
Antibody and complement play no role in the process (Rosenau and Moon, 
1961). The specific receptors on the effector lymphocytes recognize the 
responsible antigens on the cells. These can be natural components 
(Dumonde, 1966) or artificially attached antigens (Perlmann et al., 1970). 
This initial reaction triggers the subsequent killing of the target cells. 
The lymphocytes responsible for this direct cytotoxicity are T cells 
(Brunner and Cerottini, 1971; World Health Organization, 1973; Wilson, 
1963). The killing of target cells does not require blast transformation 
(Shaks and Granger, 1971; Lundgren and Moller, 1969) and is not mediated 
by released cytotoxic factors (Canty and Wunderlich, 1970). No more than 
1 to 2% of a population of lymphocytes are active (Wilson, 1965a) and, 
accordingly, a lymphocyte-target cell ratio near 100:1 is usually required 
to obtain peak activity. 
The nature of the cytotoxic reaction remains unclear although the 
effect seems to be primarily on cell membranes (Able et al., iy7u)- A 
passage of DNA and RNA from lymphocytes to target cells has been reported 
but the action on the target cell is unknown (Waksman, 1974). 
The techniques used for measuring cytotoxicity have been extensively 
reviewed and evaluated by Perlmann and Holm (1969). These techniques in­
clude simple morphological observation, counting of surviving cells or 
nuclei, production of plaques of cell lysis, use of trypan blue to esti­
mate percentages of dead cells, inhibition of cloning or colony formation, 
release of labeled nucleic acids or proteins, and release of sicr. 
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The latter technique was first utilized for studies on the survival of red 
blood cells in hemolytic diseases and has been widely employed. It was 
found to provide an excellent label for determination of cell-mediated 
lysis of tissue culture cells (Holm and Perlmann, 1967), and of chicken 
erythrocytes (Perlmann et al., 1968). s^Cr is noncovalently bound to 
proteins and other cell constituents. The chromate is reduced during 
binding and isotope is not reutilized (Holm and Perlmann, 1967). Labeling 
is rather stable in chicken erythrocytes, and the technique represents a 
sensitive index of cell damage (Perlmann et al., 1968). 
A wide variety of cells have been used as target cells in direct 
cytotoxicity systems. Tumor cells and established cell lines have been 
employed most extensively but many studies have utilized virus infected 
cells as target cells to evaluate antiviral immunity. Speel et al. (1968) 
reported a cytotoxic effect of spleen cells from mumps virus-immune mice 
on a human cell line persistently infected by mumps virus. Cytotoxicity 
was determined by visual determination of the percentage of dead target 
cells. Lundstedt (i959) used a similar technique to deLennint: ^.ylotoxic 
activity of itrenune mouse spleen cells for LCM virus-infected L cells. The 
chromium release assay was used to detect immune cytotoxic activity of 
human lymphocytes against mumps virus-infected Vero cells (Andersson 
et al., 1975), herpes simplex-infected human amnion cells (Russell et al., 
1975); BHK-21 cells persistently infected with rubella virus (Steele 
et al., 1973, 1974) and HeLa and WI-38 cells persistently infected with 
measles virus (Labowskie et al., 1974). Wilton et al. (1972) used siCr-
labeled chicken erythrocytes as a nonspecific indicator of cytotoxicity 
by human lymphocytes previously stimulated by herpes simplex virus 
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(specific stimulation). Gardner et al. (1974a) reported specific release 
of siCr from ectromelia-infected mouse embryo cells, chicken embryo cells, 
mouse fibroblasts and mastocytoma cells when incubated with spleen cells 
from ectromelia immune mice. McFarland (1974a) reported specific cyto­
toxicity of Sindbis virus-infected mouse embryo cells by Sindbis virus-
sensitized mouse spleen cells. He utilized release of ^^sj.-jgdoeoxy-
uridine to measure the cytotoxicity. 
Several of the above mentioned studies (Gardner et al., 1974a,b; 
McFarland, 1974a; Andersson et al., 1975) demonstrated that T lymphocytes 
were responsible for the cytotoxic effect. In addition, McFarland (1974a) 
reported that macrophages were responsible for clearing the virus released 
from the lysed cells and suggested that the final "recovery" in his iji 
vitro model of an acute virus infection depends on a balance between 
lymphocytes and macrophages. 
(2) Release of soluble cytotoxic mediators by sensitized lymphocytes 
-- The production of cytotoxic mediators by sensitized rat lymphocytes 
reacting witn specific antigen was first desuribeu uy Ruclcllè and naksmari 
(1968). Granger and his coworkers (Granger and Williams, 1968; Kolb and 
Granger, 1958; Granger et al., 1959) made a similar observation relative 
to mouse and human lymphocytes after stimulation by PHA, histocompati­
bility antigens and specific antigens. They introduced the term "lympho-
toxin". Production of lymphotoxin requires the presence of macrophages, 
but it is produced by T lymphocytes (Waksman, 1974). Lymphotoxin is non­
specific in action and is capable of lysing a whole variety of cell types 
including cells from different animal species. Different cells, however, 
exhibit different degrees of sensitivity to lysis by a single preparation 
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of lymphotoxin (Granger and Williams, 1971). The site of action of 
lymphotoxin seems to be the cell plasma membrane (Granger and Williams, 
1971). 
Kanra and Vesikari (1975) recently reported production of a lympho-
toxin-like mediator by lymphocyte cultures from rubella-sero positive 
human donors in response to stimulation by inactivated rubella virus. 
This preparation showed preferential cytotoxicity for rubella-infected 
target cells in comparison with uninfected cells. Therefore, more inves­
tigation is needed before this reaction can be considered true lymphotoxin 
production. 
(3) Cytotoxicity mediated by antibody to target cells and normal 
lymphocytes — Antigenic target cells, treated with certain heat inacti­
vated antisera will be damaged when exposed to lymphoid cells from un-
sensitized donors. The antisera are effective at dilutions too high to 
give rise to conventional complement-mediated lysis in the absence of 
lymphoid cells (Perlmann and Holm, 1969). The antibody responsible for 
this activity belongs to the îyG uidbb anu ail fûur siibclôsscs of 
IgG are active in this regard (MacLennan and Howard, 1972; MacLennan 
et al., 1970). 
There is lack of agreement on the type of lymphoid cell responsible 
for ihis type of cytotoxicity. Cells are activated through Fc receptors; 
modified Fc fragments of IgG bound to antigens on the surface of the 
target cell will bind to these receptors and activate the cells (Allison, 
1972a). The effector cell is not phagocytic, requires close contact with 
the target cell and kills by surface contact (Perlmann and Perlmann, 1970; 
Allison, 1972a). Early investigators considered the effector cells to beB 
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lymphocytes (MacLennan and Harding, 1970; Van Boxel et al., 1972), but 
later experimentation with extensively purified cell preparations demon­
strated that they are neither T cells nor immunoglobulin-bearing B cells 
(Greenberg et al., 1973a). Greenberg et al. (1973b) and Allison (1972a) 
considered these cells to be nonphagocytic monocytes in view of the glass-
adherent properties they observed in mice and guinea pig preparations. 
Calder et al. (1974) studied effector cells from human peripheral blood 
and, although they also considered them to be neither T nor B lympho­
cytes, they did not observe glass or plastic adherence of the human 
effector cells. Rachelefsky et al. (1975) observed a correlation between 
antibody-dependent lymphocyte cytotoxicity and the number of B cells in 
normal and immunodeficient people, suggesting that the effector cell could 
be a nonimmunoglobulin bearing B lymphocyte. 
Until recently, no experimental evidence existed to indicate a role 
for this cytotoxic mechanism in viral infections. Allison (1972a) per­
formed histological studies on liver biopsies of human patients with 
Australia antigen-pusi Live, ul iuically active hepatitis ar.d or. brains frc% 
mice with virus encephalitis. He observed that a high percentage of the 
infiltrating cells morphologically resembled the effector cells of anti-
body-madiated lymphocyte-dependent cytotoxicity, and postulated that this 
mechanism could play a role in virus-associated immunopathologic reac­
tions. Ramshaw (1975) has now provided an animal model where antibody-
mediated lymphocyte cytotoxicity seems to be the mechanism for immune 
cytolysis of infected cells; nonadherent spleen cells from herpes simplex-
infected mice lyse ^icr-labeled virus-infected target cells. This activi­
ty was not affected by treatment of the cells with anti-e serum but it was 
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abolished by anti-Ig serum. The observation that normal spleen cells can 
lyse antibody-coated target cells seems to indicate that the effector cell 
is not an inrnune B cell but a nonspecific, nonlg-bearing lymphocyte. 
Russe! et al. (1975) claimed that a similar mechanism is operative in 
humans with recurrent cold sores due to herpes simplex virus infection. 
They observed specific release of s^Cr from infected target cells after 
incubation with either lymphocytes from people with herpetic infection or 
a mixture of sera from patients (with high CF titers) and normal lympho­
cytes. They did not establish the role of T cells in affected subjects, 
however, and therefore could not rule out the possibility of more than 
one operational mechanism. 
The preceding reports emphasize the fact that many different cyto­
toxic mechanisms can be operable in different animal species or even in 
different virus-host interactions within a single species. 
(4) Cytotoxicity mediated by complement and normal lymphocytes — 
Perlmann and his coworkers (reviewed by Perlmann and Holm, 1969) have 
observed a cytotoxic effect by lymphoid cells iriyyercu L»y target cell-
bound complement. He described two different mechanisms; one is a macro-
phage-mediâtèu destruction of C'3carrying target cells (related to phago­
cytosis, following a step in iirmune adherence) and the other is a small 
lymphocyte-mediated destruction of C'7-carrying target cells. In both 
cases, the complement is bound to IgG coated target cells. 
These mechanisms differ from complement-mediated cytolysis because a 
longer period of time is required (20 hrs), the effector immunoglobulin is 
an IgG, the reaction requires antibody at much smaller concentration 
(1000-fold less) and alteration of the Fc fragment of this antibody does 
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not reduce the capacity to fix complement for this reaction. The mecha­
nism has only been observed in vitro with chicken erythrocytes and its 
biological significance is unknown. 
(5) Macrophage cytotoxicity — Many of the phenomena produced by 
cytotoxic lymphocytes can be mimicked by macrophages (Waksman, 1974). Two 
main mechanisms are operational; macrophages bearing cytophilic antibody 
or macrophages activated by mediators released from stimulated lymphocytes 
(or by other unknown mechanisms during infection). 
Macrophages coated with cytophilic antibody can duplicate many of 
the functions of sensitized T lymphocytes and, particularly, cytotoxicity. 
Evans and Alexander (1970) reported that peritoneal macrophages from 
lymphoma immune mice could inhibit the growth of these cells in vitro. 
This reaction required cell contact, and it was specific. Granger and 
Weiser (1966) reported the presence of cytophilic antibody on these 
macrophages ("armed" macrophages) and suggested that cytophilic antibody 
was responsible for this specificity of action. Even if cytophilic anti­
body is responsible for tne antigenic recogniLiun of tiicse specific 
"killer" macrophages, there is evidence indicating that the macrophages 
may require activation by an immunological reaction» mediated by specific 
T cells (Nelson, 1972; Cerottini and Brunner, 1974). If such a "specific 
macrophage-arming factor" (Cerottini and Brunner, 1974) actually exists, 
the distinction between this type of macrophage cytotoxicity and that of 
"activated" macrophages would not be so sharp. 
In Evans and Alexander's experiments (1972) it was shown that after 
the "armed" macrophages had been in contact with the specific target 
cells, they acquired the capacity to lyse other susceptible cells in a 
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nonspecific way. This suggested a two-step mechanism involved in the 
activity of macrophages from immune animals; first, "armed" macrophages 
interact with specific antigens and, second, this interaction leads to 
their activation in a nonspecific way ("activated" macrophages). 
This process shows great analogy with the concept of "activated" 
macrophages put forward to account for the increased nonspecific bacteri­
cidal activity of macrophages from immune animals (Mackaness and Blanden, 
1967; Mackaness, 1971). This acquired resistance to a large variety of 
microorganisms has been observed mainly in association with intracellular 
bacterial infections such as Listeria monocytogenes and Brucella spp. 
(reviewed by Nelson, 1969; Mackaness, 1971). It can be induced by live 
organisms only, is associated with delayed hypersensitivity, is to some 
extent nonspecific, and can be transferred passively by T lymphocytes only 
if the recipient has normal mononuclear phagocytic cells. 
There are very few reports of acquired nonspecific resistance after 
viral infections. Blanden (1970, 1971a,b), working with ectromelia virus 
infection in mice, showed that T cells were responsible for initietLitiy 
recovery and observed that nonspecific radiosensitive monocytes inade a 
major contribution to the effector mechanism (i.e., destruction of viral 
foci). Blanden and Mims (1973) reported macrophage activation that ivas 
demonstrated by an increased ability to kill Listeria monocytogenes after 
infection of mice by ectromelia or lynhocytic choriomeningitis virus. 
Pathak et al. (1974) demonstrated similar mechanisms in chickens; perito­
neal macrophages from chickens recovering from fowlpox virus infection 
showed Increased resistance to infection by Newcastle disease virus and 
Salmonella gallinarum. 
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Alexander and Evans (1971) reported an intriguing observation; 
endotoxin (or its hydrolysis product, lipid A) and viral double stranded 
RNA have the capacity to render mouse peritoneal macrophages cytotoxic to 
other mouse cells. Their study indicated that "activation" could occur 
under both in vivo and iin vitro circumstances. 
Molecular mediators Certain products of sensitized lymphoid 
cells cultured in vitro with specific antigens can simulate some of the 
phenomena associated with the expression of cell-mediated immunity. These 
products, different from immunoglobulins and producing their effects 
independently of the continued presence of antigen, have been grouped 
under the generic name of "lymphokines". 
Table 1 is a list of these factors published in a recent report of a 
World Health Organization scientific group (World Health Organization, 
1973). 
Detailed reviews of the literature concerned with these mediators 
have been published by Yoshida and Cohen (1974), Greaves et al. (1973) 
and Bloom and Glade (1971) among others. These systems have not had ex­
tensive application as in vitro correlates of cell-mediated ifrsaunity to 
viral infections. 
Macrophage migration inhibition factor (MIF) has been used to evalu­
ate cell-mediated immunity to herpes simplex virus in humans (Simmons 
et al., 1974; Wilton et al., 1972), fibroma virus in rabbits (Tompkins 
et al., 1970), rubella virus in guinea pigs (Morag et al., 1974), and 
influenza virus in humans and guinea pigs (Waldman et al., 1972). 
The immunologically specific production of interferon by stimulated 
lymphocytes was reported after herpes simplex infection in humans 
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Table 1. Biological activities of products of activated lymphocytes 
A. Affecting macrophages 
Migration inhibition factor (MIF) 
Macrophage aggregation factor (MAP) 
Macrophage chemotactic factor (MCF) 
Macrophage resistance factor 
(postulated) 
cytophilic antibodies 
inhibits the migration of 
normal macrophages 
agglutinates macrophages 
in suspension 
causes macrophages to 
migrate through micropore 
filter along gradient 
renders macrophages non-
specifically resistant to 
infection with certain 
bacteria and viruses 
confer on macrophages 
specific reactivity with 
antigen 
B. Affecting lymphocytes 
Blastogenic or mitogenic factor (BP or MP) 
Potentiating factor (PF) 
Cell cooperation or helper factor 
Suppressor factor (postulated) 
induces blast cell trans­
formation and tritiated 
thymidine incorporation 
in normal lymphocytes 
augments or enhances on­
going transformation in 
mixed lymphocyte culture 
or antigen-stimulated 
cultures 
produced by T cells, in­
creases the number or 
rate of formation of Ab-
producing cells in vitro 
inhibits activation of, 
and/or antibody produc­
tion by, B cells 
^From: Cell-mediated Inr.unity and resistance to infection. World 
Health Organization Technical Report Series No. 519. 1973. WHO, Geneva. 
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Table 1. (Continued) 
C. Affecting granulocytes 
Inhibition factor 
Chemotactic factor 
D. Affecting cultured cells 
Lymphotoxin (LT) 
Proliferation inhibition factor (rIF,CLir) 
and cloning inhibition factor 
Interferon 
E. Producing effects in vivo 
Skin reactive factor (possibly (SRF) 
a combination of several of 
the above activities) 
Macrophage disappearance factor 
inhibits the migration of 
human buffy coat cells or 
peripheral blood leuco­
cytes from capillary 
tubes or wells in agar 
plates 
causes granulocytes to 
migrate through micropore 
filter along a gradient 
cytotoxic for certain 
cultured cells, eJg., 
mouse L cells or HeLa 
cells 
inhibit proliferation of 
cultured cells without 
lysing them 
protects cells against 
virus infection 
in normal guinea pig skin 
induces indurated skin 
reactions that are histo­
logically similar to de-
layed-type hypersensitiv­
ity reactions 
injected intraperito-
neally, causes macro­
phages to adhere to 
peritoneal wall 
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(Rasmussen et al., 1974; Val le et al., 1975) and vaccinia virus in humans 
(Epstein et al., 1972). This "immune" interferon is sensitive to pH 2 and 
of higher molecular weight than the virus induced interferon (Falcoff, 
1972; Sal vin et al., 1973). 
As mentioned before, Kanra and Vesikari (1975) reported production of 
a lymphotoxin-like activity in cultures of human lymphocytes stimulated by 
rubella antigens. 
Other jn^ vitro correlates of cell-mediated immunity Ennis 
(1973) and Simmons et al. (1974) have reported a plaque size reduction 
technique as a measure of viral cell-mediated immunity. Immune guinea 
pig and mouse spleen cells prevented the spread of herpes simplex virus in 
cell monolayers. This technique correlated well with migration inhibition 
factor and skin hypersensitivity (Simmons et al., 1974). The reaction is 
solely dependent on T cell function (Ennis, 1973). 
A similar technique was reported by Rouse and Babiuk (1975) with 
immune bovine lymphocytes and IBR virus infected cells. Bovine T 
lymphocytes were reported to be the effector cells (Rouse and Babiuk, 
1974b). 
Local iimunity A very important part in resistance to infection 
is played on the mucosal surfaces by the secretory immunologic system. 
TgA is the predominant class of immunoglobulins in all secretions of man 
and many mammalian species. The relative increase in concentration of IgA 
is due to two factors: (1) local synthesis in submucosal lymphoid tis­
sues; and (2) secretion from plasma into mucosal surfaces with the aid of 
a special polypeptide, the secretory component (Spiegelberg, 1974; Rossen 
et al., 1971). 
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A secretory IgA system has also been identified in the bovine species 
where IgA is the main secretory immunoglobulin in nasal and lacrimal se­
cretions, saliva and spermatic fluid (Mach and Pahud, 1971). Its concen­
tration is very low in milk and colostrum, however, where IgG is the main 
immunoglobulin class (Porter, 1973; Butler, 1973). Although the concen­
tration of IgA is relatively high in intestinal secretions, IgM is usually 
the predominant immunoglobulin in the bovine gastrointestinal tract 
(Porter et al., 1972; Porter, 1973). 
The secretory antibody system can function independently from the 
central antibody system and can be readily activated by local application 
of antigen (Rossen et al., 1971; Todd, 1973). This fact is of extreme 
importance in many viral infections where the primary site of virus 
multiplication is either the intestinal or the respiratory tract. Studies 
of respiratory viral infection in man have shown that presence of antibody 
in nasal secretions is the best correlation of protection against viruses 
such as parainfluenza (Smith et al., 1966), rhinovirus (Rossen et al., 
lybb), and influenza virus ^riciriri el al., i5oo, Mâluwân êL al., 1909). 
Similar observations have been reported for viral intestinal infections 
such as poliovirus infection (Qgra et al., 1968). 
Studies with parainfluenza-3 virus in cattle also seem to indicate 
that secretory IgA is an important response to respiratory virus infection 
and that local respiratory iirmunity after intranasal vaccination confers 
better protection from infection than circulating antibody (Morein, 1970; 
Gutekunst et al., 1969; Marshall and Frank, 1971; Frank and Marshall, 
1971). 
36 
The induction of secretory or "local" antibody is not, however, the 
only specific immune response of the mucosal surfaces to viral infection. 
There are reports indicating that cell-mediated immune responses can also 
occur locally in the respiratory tract after intranasal infection without, 
or with a much smaller, generalized response. Waldman et al. (1972) re­
ported the occurrence of local cell-mediated immune responses to influenza 
virus in man and guinea pigs, and Morag et al. (1974) reported similar 
findings after intranasal inoculation of guinea pigs with rubella virus. 
As pointed out before, nonspecific mechanisms are also probably 
important in local protection, not only with factors such as muco-ciliary 
barriers, temperature or virus inhibitors, but also nonspecific effects of 
infection such as cellular resistance, interferon production and phago­
cytosis (Merigan, 1974). 
Recovery from virus infection 
The nonspecific mechanisms of resistance described early in this 
review determine, in many cases, the outcome of a viral infection. How­
ever, after a viral infection is deft tri Lively established with active 
virus multiplication occurring in a fully susceptible host, active defense 
responses, both specific and nonspecific^ must interplay to counteract the 
infection; fever, phagocytosis, inflammatory reactions and associated 
reactions, are among these early responses. 
Interferon production is one of the first body responses to most 
viral infections. Interferon is produced locally at the site of initial 
infection, but may be distributed in the circulation to exert a protective 
effect at sites distant from those where the virus is multiplying (Fenner 
et al., 1974). The production of interferon may be detected a few hours 
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after infection and days before the specific immune response is operation­
al. Interferon may persist for several days. High concentrations of 
interferon are present in infected tissue at the time virus concentrations 
begin to fall (Bellanti and Artenstein, 1964; Baron, 1970). Passive 
transfer of interferon indicated that circulating interferon can reduce 
the viremia and reach target organs to protect cells against subsequent 
seeding of virus from the blood (Baron et al., 1966a,b; Pinter, 1966). 
In the absence of specific inhibitors of interferon production, or 
genetically deficient experimental animals, it is very difficult to evalu­
ate the importance of interferon in promoting recovery. Decreased func­
tion of the interferon system caused by altered body temperatures, stress, 
chemical inhibitors and different virus strains has led to impaired re­
covery of laboratory animals (Baron, 1970). Genetic differences in inter­
feron responsiveness determined the severity of arbovirus B infection in 
mice (Hanson et al., 1969). 
Experiments with immunosuppressive agents have shown that, in some 
instances, normal levels of interferon fail Lu jjrùLect animals frcm viral 
infections if the specific immunologic reactions are rendered inoperative 
by immunosuppression (Glasgow, 1971). 
The appearance of specific immunologic responses brings into play the 
most powerful defense mechanisms to eliminate the infection, but it is 
often difficult to discern which effector mechanisms are more important in 
particular infections. Experiments with immunosuppression and restoration 
by antibody, as well as clinical observations in immunodeficiency states, 
have revealed that viruses that promote systemic disease with viremia are 
probably controlled primarily by circulating antibody. Enterovirus and 
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arbovirus infections fall into this category and these viruses even fail 
to elicit a cell-mediated irrenune response in most cases (Allison, 1972a,b; 
Notkins, 1974). On the other hand, viruses which spread from cell to cell 
through intercellular bridges, and which usually elaborate specific anti­
gens on the cell surface, are more likely to be protected from circulating 
antibody and to elicit cell-mediated immune responses (Allison, 1972a,b; 
Notkins, 1974; World Health Organization, 1973). Herpesviruses, pox­
viruses and some myxoviruses, as well as oncogenic viruses (which although 
showing vertical transmission very often induce specific antigens on the 
cell surface) would be included in this group (Notkins, 1974). The ques­
tion arises concerning the mechanism of action of cell-mediated immunity. 
How do cell-mediated immune responses act in vivo to eliminate infection? 
What is the in vivo function of the in vitro correlates of cell-mediated 
immunity? The following is an excerpt from the World Health Organization 
Scientific Group Report (World Kealth Organization, 1973): 
..."sensitized lymphocytes circulate and become stimulated to 
synthesize biologically active products when they interact with 
specific antigen in the tissues, the chemotactic fauLor mlynt 
be responsible for the accumulation of monocytes and macrophages 
at sites of antigen implantation; the blastogenic factor might 
activate adjacent lymphocytes in the tissues, i.e., act as an 
amplification mechanism for the few sensitized cells at the 
site; the migration inhibition factor might arrest macrophages 
at the site of the reaction; and the postulated macrophage re­
sistance factor might account for the increased nonspecific 
resistance to infection of macrophages, although for this effect 
cell-cell interaction might be required. Infected or otherwise 
antigenically altered cells might be destroyed or limited in 
their growth by lymphotoxin and the proliferation inhibition 
factors; and uninfected cells might be protected from viral 
infection by interferon." 
This is a qualitative interpretation of the events that may occur in 
certain cell-mediated reactions based on the existence of the lymphokines. 
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However, the interpretation is purely speculative since it has not been 
tested in vivo. Salvin et al. (1973) reported the isolation of migration 
inhibitory factor and "inmune" interferon from blood within hours after 
intravenous inoculation of tuberculin into BCG-sensitized mice, but this 
observation sheds little light on the mechanism of action in vivo. 
Efforts to isolate lymphokines from tissues, on the other hand, have con­
sistently been unsuccessful (Yoshida and Cohen, 1974). 
Cytotoxic reactions of lymphocytes are very likely to be important in 
the control of virus infections (World Health Organization, 1973), partic­
ularly in the case of oncogenic or noncytolytic virus infections, but 
their role in cytolytic infections is difficult to assess. 
If lymphocyte-mediated cytotoxic reactions do take place, a coopera­
tive role of circulating antibody and complement in the destruction of 
virus-infected cells cannot be ruled out. Kibler and Meulen (1975) and 
Russell et al. (1975) have reported production of cytotoxic antibody in 
people after measles and herpes simplex infections. A whole range of 
virus-infected cells can be destroyed in vitro py antiviral antibuûy cmû 
complement (Porter, 1971; Notkins, 1971). Lodmall et al. (1973)» working 
in an entirely in vitro system, showed that the only wsy to "cure" herpes 
simplex-infected cell cultures was by a cooperative effect of leukocytes 
and antibody plus complement; antibody and complement alone failed to 
stop the spread of the virus from cell to cell, and leukocytes alone 
halted the spread only temporarily. 
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Immunosuppression During Viral Infections 
The depression of immune responses during viral infections has re­
ceived increasing attention in the last 10 or 15 years. The first report 
by Von Pirquet (1908) on the abrogation of tuberculin=delayed hyper­
sensitivity by measles infection was forgotten and the subject neglected 
for more than half a century. After Old et al. (1960) reported that 
Friend leukemia virus impaired the ability of infected mice to produce 
antibodies to sheep red blood cells, a number of investigations were ini­
tiated in different laboratories and conclusively demonstrated that viral 
infection can interfere with normal itranune function. 
Notkins et al. (1970), Sal aman (1970) and Dent (1972) have published 
very extensive reviews of the work on immunosuppression caused by onco­
genic and nononcogenic viruses. They included reports of decreased 
humoral responses to a variety of nonreplieating antigens during infection 
with a number of oncogenic viruses such as Gross virus, Moloney virus, 
Frisnd virus, Rauscher virus and Marek's disease virus. Lymphocytic 
choriomeningitis virus, Newcastle disease virus, Junin virus, murine 
cytomegalovirus and Aleutian mink disease virus were among the nononco­
genic viruses reported to produce depression of humoral responses. 
Most of the early work dealt with antibody responses only, but in a 
few cases where call-mediated immune responses were studied, host versus 
graft reactions were shown to be impaired in infections with Gross leu­
kemia virus and Marek's disease virus. Persistent skin hypersensitivity 
reactions were temporarily abrogated during infections by measles. 
41 
influenza, chickenpox and poliovirus. Impaired phagocytosis was reported 
during ectromelia, lymphocytic choriomeningitis and Dengue virus infec­
tions. 
The rather extensive list of immunosuppressive viruses comprises 
agents with a wide range of biological effects, both in disease causing 
ability and immunosuppressive potential. This immediately suggests dif­
ferent mechanisms of action by various viruses, an idea supported by the 
still inconclusive evidence concerning their effects on the iimune sys­
tem. Several mechanisms have been proposed: 
(1) Antigenic competition — The possibility that the immunosuppres­
sive virus competes as an antigen with the test antigen was raised during 
the early work with leukemogenic viruses. This hypothesis has been 
largely discarded due to the poor antigenicity of most leukemia viruses, 
differences in time intervals and effects on secondary responses from the 
classical characteristics of antigenic competition, and the lack of cor­
relation between virus recovery and immunosuppression in some systems 
(Dent, 1972). 
(2) Competition for a cossîîofî stem cell -- This hypothesis was 
postulated by Siege! and Morton in 1965 to explain the fact that most 
leukemogenic viruses do not alter ongoing antibody synthesis and depress 
primary responses to a greater degree than secondary responses. They also 
suggested that prolonged antigen and adjuvant treatment impaired leukemo-
genesis by previous differentiation of susceptible stem cells into anti­
body-forming cells (Siegel and Morton, 1967). Bennet and Steeves (1970) 
observed a differing susceptibility to cortisone treatment in precursors 
of plaque-forming cells and Friend virus focus-forming cells suggesting 
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that, at least in the sheep erythrocyte-Friend virus system, antigenic 
competition for a common precursor cell does not exist. 
(3) Alteration of immunocompetent cells -- Although this simple ex­
planation probably does not apply to many of the long-latent-period leu-
kemias (Dent, 1972), it agrees with the findings in many of the acute, 
nonortcogenic virus infections. Many of the viruses known to cause immuno­
suppression possess the ability to grow in leukocytes (Gresser and Lang, 
1966). Many of these infections usually result in metabolic depression of 
the cells. Will ems et al. (1969) observed reduction of PHA responses in 
human leukocytes infected by poliovirus, echovirus, influenza virus, 
Sendai virus, Newcastle disease virus, vesicular stomatitis virus, herpes 
simplex virus, vaccinia virus, adenovirus and papilloma virus. Vaccina­
tion of man with live rubella virus vaccines also results in temporary 
inhibition of lymphocyte responses to PHA (McMorrow et al., 1974", Vesikari 
and Buimovici-Klein, 1975). Kantzler et al. (1974) observed temporary 
loss of preexisting skin hypersensitivity to a variety of antigens and 
suppression of the lymphocyte response to PHA drier influenza virus in 
fection in man. These studies have been considered as indicators of sup­
pression of T cell responses, although no investigations were made of the 
possible influence of the infection on B cell functions. However, Bro-
0(6rgensen et al. (1975) in a more comprehensive study involving several 
parameters of T and B cell function in lymphocytic choriomeningitis virus-
infected mice, demonstrated selective suppression of T-cell function. 
Similar results were reported by McFarland (1974b)on studies of measles 
infection in mice. He reported decreased antibody response to carrier-
hapten conjugates due predominantly to a defect in T helper cells 
43 
(although B cells may have been affected to a lesser extent). Fuccillo 
et al. (1974) observed that children with congenital rubella infections 
usually show antibody titers to this virus, but no cell-mediated immunity. 
This finding may possibly explain the persistent virus excretion during 
this condition. 
Murine cytomegalovirus seems to produce more generalized effects on 
the immune system. Howard and Najarian (1974) and Howard et al. (1974) 
reported depression of both humoral and cell-mediated immunity in mice. 
The mechanism was associated with cytolytic infection of the lympho-
reticular system which showed necrotic lesions and maximal virus content 
at the time of maximal suppression of immune response. 
The observation of low antibody responses to Newcastle disease vac­
cines in chickens with serological evidence of infection with infectious 
bursal disease suggested the possibility of B cell deficiencies caused by 
the virus. This observation is plausible since the virus is known to 
specifically affect the bursa of Fabricius (Harris, 1974). 
(4) Alteration of macrophage function -- riotkins (1965) observed LliaL 
a functional impairment of the reticuloendothelial system was the only 
clinical pathological observation in mice infected with lactic dehydro­
genase virus (LDV). LDV causes changes in immune responses of mice 
usually evidenced as enhanced antibody synthesis, depressed cell-mediated 
responses and depressed phagocytic function (Notkins et al., 1970). These 
observations are consistent with the finding that maximal concentrations 
of LDV virus are usually associated with macrophages (Evans and Sal aman, 
1955). 
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Mumps vaccine is another example of a live virus vaccine that can 
affect preexisting delayed hypersensitivity. Hall and Kantor (1972) 
recently showed that this effect is caused by inhibition of the nonspe­
cific effector cells (monocytes) and not of the specifically sensitized 
cells (T cells); picryl-albumina sensitivity was successfully transferred 
from the infected guinea pig with depressed skin sensitivity to normal 
recipients. Transfer to infected animals of a new specificity, bovine 
gammaglobulin, was not as successful as transfer into controls. 
K.leinerman et al. (1974) observed that herpes simplex and influenza 
virus infections in man greatly reduced the chemotaxis of blood monocytes. 
This finding suggested that the action of these viruses on cell-mediated 
inrnune responses could be due to their influence on mononuclear effector 
cells. 
Poliovirus has also been shown to replicate in human leukocytes and 
to inhibit their response to PHA (Willems et al., 1959). Soontiëns and 
Van der Veen (1973) have presented some evidence indicating that polio-
virus inhibits the response to PHA by suppressing the enhancing effect or 
macrophages rather than by direct action on lymphocytes. 
These reported experiments indicate that, at least In acute nononco-
genic viral infection, immunosuppression could be due to direct attack on 
cells of the lymphoid system, since most of these viruses have been shown 
to multiply in vitro in leukocyte cultures. The extent of the suppressive 
response probably depends on the degree of functional impairment of the 
lymphoreticular system. Although most of the studies described above have 
not been extended to both humoral and cell-mediated responses, the latter 
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seem to be more susceptible to the mild immunosuppressive effects clini­
cally observed during viral infection or after vaccination of man. 
Bovine viral diarrhea (BVD) virus has an affinity for cells of the 
immune system and destruction of lymphoid tissues can be observed in 
natural cases of the disease (Ramsey, 1956; Pritchard, 1963). There are a 
few reports on field cases of the disease or on postvaccinal reactions 
that suggest that immunosuppression can occur in cattle during BVD infec­
tion (Peter et al., 1967; McKercher et al., 1968; Brown and Andrews, 
1973). Shope (1964) and Muscoplatt et al. (1973a) contended that fatally 
infected cattle failed to develop BVD neutralizing antibodies even after 
protracted clinical illness. This failure of an antibody response does 
not always occur, however, as indicated by the author's experience as well 
as the experience of others with field cases of the disease (Brown and 
Andrews, 1973). 
The best evidence for a possible immunosuppressive role of BVD infec­
tions came from studies of the ability of the virus to grow in leukocytes 
and its role in lymphocyte responses to PHA. Truitt ctnti Slieoniiicistsr 
(1973) reported that BVD virus can multiply in vitro in bovine lymphocytes 
and macrophages. PHA stimulation of infected cells usually results in 
increased virus titers. Cells from both immune and susceptible cattle 
supported virus growth equally well. Muscoplatt et al. (1973a) reported 
inhibition of lymphocyte response to PHA after in vitro or in vivo infec­
tion. There are no reports, however, on the effect of BVD virus infection 
on specific immunologic responses. 
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Immune Responses in Cattle to IBR and BVD Viruses 
Recovery from natural infection with BVD ordinarily confers solid, 
long-lived immunity to subsequent infections (Pritchard, 1963). High 
serum antibody titers usually result from either infection or vaccination 
with live virus. A number of serological techniques have been used to 
quantitate those responses (reviewed by Classick, 1970). Complement 
fixing antibodies are detectable approximately 3 weeks after infection and 
persist for only a few weeks or at most up to a few months. Neutralizing 
antibodies, first detected 2-3 weeks after infection, tend to persist for 
much longer periods of time (Ruckerbauer et al., 1971). In utero infec­
tion of bovine fetuses 168 days or older results in development of neu­
tralizing antibodies (Casaro et al., 1971). This fetal response is com­
posed of both IgM and IgG immunoglobulins (Braun et al., 1973). 
Rosenquist (1973) reported that most calves infected intravenously with 
BVD virus failed to produce detectable circulating interferon. 
There are no reports of secretary in^nunity or cell-mediated immune 
responses to BVD virus. The report by Truitt and Shechmeister (1973) that 
leukocytes from "immune" cows supported viral growth at the same rate as 
cells from normal cows, suggested that those lymphocytes lacked antiviral 
properties. 
The immunity elicited to the respiratory form of IBR virus infection 
is strong and long lasting, but immunity to the genital form affords short 
term protection (McKercher, 1973). A carrier state follows active 
infection and, despite strong immunity to reinfection, there is inter­
mittent shedding of virus for long periods of time (Snowdon, 1965; Bitsch, 
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1973). Almost all of the early neutralizing antibody response to I BR 
virus is composed of complement-dependent IgM, later followed by noncom-
plement-dependent IgG (Potgieter, 1975). This early IgM antibody is al­
ready present at high titers at 8 days postinoculation. 
Cell-mediated immune responses to IBR virus, as measured by lympho­
cyte transformation, are first detected at 5-6 days postinoculation, 
peaking between 7 and 10 days postinoculation, and vanishing before the 
third week postinoculation (Davies and Carmichael, 1973; Rouse and Babiuk, 
1974a). Nonadherent, nonimmunoglobulin bearing small lymphocytes, pre­
sumably T cells, are responsible for the antigen specific stimulation and 
for inhibition of viral plaques in cell monolayers (Rouse and Babiuk, 
1974b). 
Interferon is produced in response to IBR infection or vaccination 
with live virus vaccines. Rosenquist (1973) reported production of high 
titers of interferon in serum after intravenous inoculation of virulent 
virus and lower titers after intramuscular or intratracheal inoculation. 
Todd et ai. (ly/z) detected high titers uf itiLerTetOn in nasal secretions 
of calves following intranasal vaccination with a vaccinal strain. High 
titers were present during the period between the third and the eighth 
days postinoculation. Low serum titers were observed between the fourth 
and the eighth days. 
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MATERIALS AND METHODS 
General Methods 
Cell culture media and reagents 
Minimum essential medium^ (MEM, Eagle) with Earle's salts 
Earle's balanced salt solution^ (EBSS) 
Hanks' balanced salt solution^ (HBSS) 
Medium 199 with L-glutamine and 25 mM Hepes buffer^ (M 199) 
Phosphate buffered saline pH 7,5 (PBS) 
0.1 M KCl-HCl buffer pH 2 and pH 3 
2 Fetal calf serum (PCS) - A single batch, screened for virus and 
mycoplasma, and free of BVD and IBR antibodies, was used in virus isola­
tion, virus propagation and all the lymphocyte cultures. 
3 Penicillin was used at a concentration of 100 units/ml. 
Streptomycin" was used at a concentration of 100 vg/ml. 
3 Fungizone was used at a concentration of 0.25 yg/ml. 
Gentamicin* was used at a concentration of 50 vy/ml. 
Bovine testicle cell cultures 
Calf testicles were obtained from a commercial abattoir Ir: Dubuque, 
Iowa. The parenchyma of these organs was removed, minced and trypslnizsd 
^Grand Island Biological Co., Grand Island, New York. 
p 
International Scientific Industries Inc., Cary, Illinois. 
^E. R. Squibb and Sons s New York, New York. 
^Schering Corp., Port Rsading, New Jersey. 
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in a 0.25% trypsin^ solution. Dispersed cells were suspended at a con­
centration of 1.5 million cells/ml in a growth medium that consisted of 
MEM plus 0.22% sodium bicarbonate, 10% fetal calf serum, penicillin and 
streptomycin. The cells were dispensed into 60 mm plastic tissue culture 
2 2 plates for virus isolation tests or into flasks for later preparation of 
secondary cell cultures. For the preparation of secondary cell cultures, 
monolayers were trypsinized with Trypsin-EDTA^ suspended at a 1 to 6 
dilution in growth medium and dispensed into flasks for virus propagation 
or into plastic tissue culture plates containing 24 (16 m) wells for 
interferon assays. All cultures were incubated at 37 C in an humidified 
CO2 cell culture incubator. 
Each batch of bovine testicle cells was screened for the presence of 
noncytopathogenic BVD virus by infecting 60 mm tissue culture plates with 
a known number of plaque forming units (PFU) of BVD virus (NADL strain). 
The plates were incubated for 5 days and observed for evidence of inter­
ference (reduction in number of PFU). 
Viruses 
Bovine viral diarrhea (SVD) viruses Two strains of BVD viruses 
were used. The NADL Strain (number of tissue culture passages unknown) 
was used for virus neutralization tests and for antigen preparation. 
Strain 1015-74 was used for animal inoculation and antigen preparation. 
^Difco Laboratories, Detroit, Michigan. 
2 Falcon Plastics, Los Angeles» California. 
3 Linbro Chemical Co., Inc., Msw Haven, Connecticut. 
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This strain was isolated at the Iowa Veterinary Diagnostic Laboratory from 
a typical case of bovine virus diarrhea-mucosal disease where it affected 
50% of a group of yearling calves with very high mortality. Several 
calves were necropsied in this outbreak with all of them presenting typi­
cal lesions of the disease. BVD virus was repeatedly isolated. No other 
viral or bacterial pathogen was recovered. This isolate was plaque puri­
fied and used at the third bovine testicle passage as a challenge strain. 
Infectious bovine rhinotracheitis (IBR) virus Strain VOL 353 
A-72, isolated at the Iowa Veterinary Diagnostic Laboratory from a typical 
case of infectious bovine rhinotracheitis, was used at the fifth bovine 
testicle passage for animal inoculation and antigen preparation. 
A type strain of IBR virus, originally obtained from the National 
Animal Disease Center, Ames, Iowa, was used for antigen preparation and 
serological tests. 
Vesicular stomatitis virus (VSV) VSV (New Jersey) was obtained 
from Dr. L. Potgieter, Department of Veterinary Microbiology, Iowa State 
University. It was propagated in secondary bovine tesLiule lkHs aim used 
for the assay of interferon. 
Equine rhinopncumonitis virus (ERV) A live modified vaccine 
strain^ (Rhinomune) of ERV was used as a control antigen preparation in 
the cytotoxic assay. 
Virus propagation 
Confluent secondary testicle cell monolayers were infected with IBR, 
VSV or BVD viruses (approximately 0,1 to 0.5 PFU/cell). After allowing 
^Norden Laboratories, Lincoln, Nebraska. 
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viral absorption to proceed for 90 minutes at 37 C, maintenance medium 
(MEM with 1% PCS) was added. The cells were incubated until 90% were de­
tached, usually 24 hrs for VSV, 48 hrs for IBR and 5-6 days for BVD. 
Cellular debris was removed by centrifugation at 1000 x g for 10 
minutes at 4 C. The challenge viruses and VSV virus were divided into 
aliquots and held at -70 C until use. The virus for antigen production 
was held at 4 C until use. 
Viral antigens for lymphocyte stimulation 
IBR and ERV virus suspensions were centrifuged (50,000 x g; 4 C) for 
1 hr; BVD virus suspensions were centrifuged (85,000 x g; 4 C) for 2 hrs. 
An IEC B-60 centrifuge^ with an A-321 rotor was used. The IBR and ERV 
pellets were resuspended in 1/10 of the original volume; BVD pellets were 
reconstituted at 1/15 the original volume. The titers of the resuspended 
virus were 10® PFU/ml for IBR and 5x10® PFU/ml for BVD. ERV was not 
titrated. The IBR and ERV viruses were inactivated by heating at 56 C for 
1 hr; BVD was inactivated by heating at 56 C for 2 hrs. The antigen 
preparations were held at -70 C until use. 
Serum virus neutralization test 
Antibody titrations were performed in a virus neutralization micro-
test, according to Jenney and Wessman (1973). The only modification to 
this method was the addition of complement; fresh guinea pig serum (C) 
or heat inactivated guinea pig serum (HC) was added to the serum-virus 
mixtures. Briefly, two sets of 0.05 ml volume twofold serial dilutions of 
the sera in EBSS were made in flat bottom tissue culture microtiter 
1 
'International Equipment Co., Needham Heights, Massachusetts. 
52 
plates J IBR or BVD viruses (25 TCID50) were added in 0.05 ml volumes. 
To one set of diluted serums, 0.025 ml of HC was added; 0.025 ml of C 
was added to each well of the second set. The plates were incubated for 
1 hr at room temperature. Bovine testicle cells in a 75 cm^ flask were 
trypsinized during the neutralization period, suspended in 10-15 ml MEM 
with 10% PCS and 0.05 ml of the cell suspension dispensed to each well of 
p 
the test plate. Two drops of mineral oil were added to each well, and 
the plates incubated until 80-90% cell destruction was observed in the 
control wells at which time the test was read. Serum, cell, virus and C 
controls were included. 
Virus isolation 
Virus isolations were conducted in primary bovine testicle cell 
cultures in 60 mm plastic plates with an agar overlay. The agar overlay 
consisted of MEM with 1% Noble agar^ and 2% PCS plus antibiotics. Cul­
tures were incubated for 8 days, and observed daily for appearance of 
viral plaques. Viral plaques, when observed? were harvested and the 
virus seeded in Leighton tubes tor identificaxion. virus ideniifitaLturi 
was conducted by a direct fluorescent antibody method using BVD and !BR. 
specific conjugates.^ 
^Falcon Plastics, Los Angeles* California. 
^E. R. Squibb and Sons, New York, New York. 
3 Difco Laboratories, Detroit, Michigan. 
diagnostic Virology Section, Veterinary Services Diagnostic Labora­
tory, APHIS, Ames, Iowa. 
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When no viral plaques were observed, the cells were harvested and 
repassed in primary bovine testicle cell cultures. Samples were con­
sidered negative when no viral plaques were observed in this second 
passage. 
Interferon assay 
Serum samples and supernatant fluids from lymphocyte cultures were 
assayed for interferon activity by a plaque reduction method using VSV 
as the indicator virus. Twofold serial dilutions of the samples were 
made in MEM with 1% fetal calf serum. The dilutions, in 0.5 ml volumes, 
were inoculated into plastic tissue culture plates^ possessing 24 (16 mm) 
wells containing monolayers of secondary bovine testicle cells. 
The cells were incubated for 18-20 hrs, the supernatant fluids were 
aspirated and the cells washed twice with 1 ml of HBSS. A suspension of 
VSV in EBSS was adjusted to contain 200-300 PFU/ml and 0.1 ml was inocu­
lated into each well. After incubation for 1 hr at 37 C, excess fluid was 
aspirated and the cells were covered with 0.5 ml of agar overlay contain­
ing 1% PCS. The plates were incubated at 37 C for 48 hrs, observed for 
cytopathic effect and interferon titers were determined. 
Experimental Procedures 
Experimental animals 
Eighteen 700-750 lb steers were used in the experiments. These 
steers were selected on the basis of complete absence of BVD and IBR 
antibodies in a representative number of serum samples obtained from 
1 
Linbro Chemical Co., New Haven, Connecticut. 
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animals in the herd of origin. Three of the steers were used in pre­
liminary experiments to determine susceptibility to BVD virus and to 
select a challenge strain. The remaining 15 steers were inoculated with 
BVD virus alone, IBR virus alone or a combination of both agents (Table 
2). 
Table 2. Design of the experiments. Treatment of animals 
Experiment BVD-l® ByD-2b IBR 
1 33Cf-331-336-346 -
2 335-337-BR 330-336 
3 332-344 331-346 
4 HRT-343 • -
5 333-347 333-347-330-331 
6 341-NT 341-NT-335-337 
^First inoculation. 
'^Reinoculation. 
^Animal identification. 
The BVD virus inoculum consisted of 10 ml of a 5 x 10^ PFU/ml viral 
suspension in EBSS with 2% PCS administered intravenously. 
The IBR virus inoculum consisted of 10 ml of a 5 x 10? PFU/ml viral 
suspension in EBSS with 2% FCS administered by the intranasal routs. IBR 
virus was administered on the second day following BVD inoculation. 
Body temperature and total white blood cell counts (WBCC) were de­
termined daily. Nasal swabs and blood samples (with and without EDTA 
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anticoagulant) were collected for virus isolation. The samples were col­
lected daily during the first week following inoculation and at variable 
intervals thereafter= Serum samples were collected daily during the first 
week postinoculation for interferon assay. 
Isolation of lymphocytes 
Blood (200-250 ml) was collected by venipuncture into 1000 ml 
Erlenmeyer flasks containing nine 6-inch wooden applicator sticks, at­
tached to each other near one end so as to fonn a vertical "cone" (Kay and 
Kaeberle, 1972). The blood was defibrinated by swirling by hand or by 
shaking in a mechanical shaker for 10 minutes. 
The defibrinated blood was transferred to 50 ml siliconized screw-cap 
centrifuge tubes (25 x 150 mm) and centrifuged at 750 x g for 40 minutes 
in a swinging bucket-type centrifuge.^ The buffy coat cells were aspi­
rated with a pipette and suspended in 2 volumes of sterile physiological 
saline solution (0.85% NaCl). 
An 8 ml quantity of this suspension was carefully layered onto 4 ml 
9 
of Ficoll-Hypaque (specific gravity 1.060) in à 13 x 100 ml plastic tiibc" 
and centrifuged at 400 x g for 30 minutes. 
The Ficoll-Hypaque solution was prepared by mixing 29,4 ml of Hypaque 
solution (20 ml 50% Hypaque^ with 9.4 ml distilled water) with 53.33 ml of 
a 10% Ficoll^ solution. 
1 International Equipment Co., Needham Heights, Massachusetts. 
^Falcon Plastics, Los Angeles, California. 
Winthrop Laboratories, New York, New York. 
^Pharmacia Fine ChemicalS; Piscataway, New Jersey. 
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The specific gravity was measured with a hydrometer and adjusted to 
1.080 with distilled water. The mixture was sterilized by filtration 
through a 0.45 p membrane filter.^ 
The lymphocytes were aspirated from the interface with a pipette, 
washed once in HBSS without Ca or Mg and suspended in the growth medium. 
Further purification of lymphocytes 
Lymphocytes for some of the cytotoxic assays were further purified 
by filtration through cotton fiber columns (Kay and Kaeberle, 1972) or 
nylon wool columns (Julius et al., 1973). 
The cotton fiber columns were made by partially filling 12 ml dis-
2 posable plastic syringes with cheesecloth threads. The columns were 
washed with HBSS, and sterilized by autoclaving. 
3 The nylon wool was removed from Leuko-Pak filters and washed by 
soaking the content of one filter in a 1 liter beaker containing glass 
distilled water at 37 C. Several changes were made over a period of 5 
days. After manually expressing water, the wool was dried at 37 C. About 
U.b gr of dry wool ms packed into a 12 ml syrinye.^ Trie CuluiiinS were 
sterilized by autoclaving, rinsed with sterile phosphate buffered saline. 
pM 7.2, containing 5% fetal calf serum, and placed in an incubator at 37 C 
for 1 hour before loading with cells. 
Both types of columns were loaded with approximately 10® lymphocytes 
in a 1 ml volume, washed into the column with 1 ml additional medium, and 
^Millipore Filter Corp., Bedford, Massachusetts. 
2 Monoject, Sherwood Medical Inds.s Deland, Florida. 
3 Fenwal Laboratories, Morton Grove, Illinois. 
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incubated at 37 C for 45 minutes. The columns were then washed slowly 
with 20-25 ml of growth medium, the cells pelleted by centrifugation at 
200 X g for 10 minutes and resuspended in fresh medium. 
Plastic adherent and nonadherent cells were separated by incubating 
5 to 8 X 10"^ Ficoll-Hypaque purified cells in 25 cm^ plastic tissue cul­
ture flasks for 1-2 hours. Adherent cells were detached by trypsinization 
with 0.25% trypsin for 20-30 minutes, washed in HBSS and resuspended in 
M199. 
Lymphocyte cultures 
The growth medium for lymphocyte cultures consisted of M199 supple­
mented with 20% PCS, gentamicin and fungizone. Ficoll-Hypaque purified 
lymphocytes were suspended in growth medium to a concentration of 1.5 x 
10® cells/ml, and 2 ml of this cell suspension were dispensed into dry 
heat-sterilized glass culture tubes^ (13 x 125 mm) with Morton stainless 
steel closures. Mitogens and antigens were then added in 0.1 ml volumes 
O 
to the tubes. Phytohemagglutinin-P (PHA-P) was used at 1:50 dilution and 
poKeweea mitogen" (PWri) at a 1:10 dilution in growth medium. 
Two sets of triplicate cultures were prepared for each of the anti­
gens, mitogens and control cultures. Lymphocyte cultures were incubated 
at a 30' angle in a 5% COg humidified atmosphere at 37 C. One set of 
cultures was used to measure DMA incorporation by stimulated lymphocytes. 
The supernatants of the second set of cultures, incubated for the same 
^ RTU #7824; Beckton; Dickinson and Co., Rutherford, New Jersey. 
P Difco Laboratories, Detroit, Michigan. 
Grand Island Biological Co., Grand Island. New York. 
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period of time, were used for interferon assays. The pooled supernatants 
of each triplicate culture were kept frozen at -20C until assayed. 
Termination of lymphocyte cultures for DNA analysis 
One yCi of tritiated thymidine with a specific activity of 6.7 Ci/ 
in a volume of 0.1 ml, was added to each tube 22-24 hrs before 
termination of the cultures. Mitogen stimulated lymphocytes were incu­
bated for a total of 72 hrs. Antigen stimulated lymphocytes were incu­
bated for 5 total time of 120 hrs. 
At the termination of the incubation time, the cultures were centri-
fuged at 1000 x g for 15 minutes, the supernatant fluid decanted into a 
radioactive waste container, and the cells resuspended in PBS. After a 
second centrifugation the supernatant fluids were decanted and the tubes 
containing the cell pellets were immediately frozen at -20C and kept 
frozen until prepared for DNA analysis. 
DNA analysis 
The cell pellets were thawed and 1 drop of newborn calf serum was 
added to esch tube. The cultures were Incn precipitated with cold 5% 
trichloroacetic acid (TCA); 3 ml were added to each tube and maintained at 
4 C for at least 1 hour. The precipitates were sedimented by centrifuga­
tion at 1,500 X 9 for 20 minutes at 4 C, the supernatant fluid was dis­
carded and a 3 ml volume of TCA was added for a second precipitation step. 
After centrifugation, the pellets were resuspended in 1 ml ice-cold 
methanol, immediately centrifuged, the methanol discarded, and the re­
sidual precipitate dried at room temperature. The precipitated DNA was 
^New England Nuclear Corp., Boston, Massachusetts. 
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solubilized in 0.5 ml Soluene-100\ 10 ml of toluene-base scintillation 
fluid (Permafluor^) was added, and the samples transferred into counting 
p 
vials. Samples were counted for 10 minutes in a Packard TriCarb model 
3375 liquid scintillation counter.^ 
Cytotoxic assay 
Lymphocyte suspensions were assayed for cytotoxic activity by using 
virus-coated chicken erythrocytes prepared according to a modification of 
the technique described by Schirrmacher and Golstein (1973). Fresh 
chicken red blood cells (CRBC) were coated with viral antigens by means of 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-HCl (ECDI)^; 0.1 ml of a 
50% suspension of washed CRBC was added to 1 ml of each viral antigen, 
0.2 ml of ECDI (50 mg/ml in PBS) was added, and the mixture incubated for 
1 hour at room temperature. The cells were washed three times in normal 
saline solution, and resuspended to approximately a 1% suspension (ad­
justed to a concentration such that after lysis of an aliquot in 39 
volumes of distilled water, the mixture exhibited a 77-78% transmittance 
in a Spectronic-2ù* spectrophuLunieLtt} in sal inc. The cells ware labslsd 
with sicr^ by incubating 1 ml of the CRBC suspension with 100 yCi of sicr 
for 1 hour at room temperature. The cells v.-ere washed twice in normal 
saline solution and resuspended in 2 ml of normal saline solution. 
^Packard Instrument Co., Downers Grove, Illinois. 
p 
Wheaton Scientific, Milville, New Jersey. 
3 Sigma Chemical Co., St. Louis, Missouri. 
^Bausch and Lomb Inc.* Rochester, New York. 
5 ICN Isotope & Nuclear Div., Irvine, California. 
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Cytotoxicity was assayed by adding 1.5 to 2 x 10^ lymphocytes to 0.1 
ml aliquots of labeled CRBC in 13 x ICQ mm sterile disposable plastic 
tubes. The final volume was adjusted to 0.8 ml. The cells were centri-
fuged at 1200 x g for 1 minute to assure cell contact, and then incubated 
for 18-20 hrs at 37 C, At the end of the incubation period, the tubes 
were centrifuged at 1500 x g for 10 minutes and the supernatant fluids 
separated from the pellets. Radioactivity of both cell pellets and super-
natants was determined in a Picker Nuclear Autowell II gamma counter.^ 
B cell counts 
The percentage of immunoglobulin bearing cells in Ficoll-Hypaque 
isolated lymphocytes was determined by staining the lymphocyte suspensions 
2 
with a rabbit antibovine globulin fluorescent conjugate. Lymphocytes 
were suspended in HBSS at a concentration of 10?/ml; 0.1 ml of the cell 
suspension was added to a 0.2 ml volume of a 1:20 dilution of the con­
jugate and incubated at room temperature for 20-30 minutes. The cells 
were immediately washed in 5 to 7 ml of HBSS containing 0.1% sodium azide, 
and resuspended in 3-4 drops uf HBSS. The percar.tagG cf i%%unoglobulin-
bearing cells was determined by counting fluorescent cells and total cells 
in an Ortholux II Leitz microscope with epi^'1uc>''=scGnt illumination. 
Blood cultures 
Bacterial examination of peripheral blood was conducted by inocula­
tion of venous blood into medium in commercial blood culture bottles. 
Vicker Corp., New Haven, Connecticut. 
p 
Colorado Serum Co.s Denver, Colorado. 
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Bacto brain heart infusion blood culture bottles^ were used in experiments 
2 I through IV. Vacutainer Columbia broth blood culture bottles and Vacu-
tainer Columbia broth with sodium polyanethol sulfonate (SPS) blood cul-
2 ture bottles were used in experiment VI and in blood cultures from 10 of 
the calves conducted twice after the end of the last experiment. 
The skin was prepared by clipping the hair and disinfecting with 70% 
alcohol or 1% tincture of iodine. Blood cultures were directly performed 
by jugular venipuncture with blood collection sets^ or by collecting the 
blood in sterile disposable 30 ml syringes and subsequent inoculation of 
the culture bottles. Approximately 5 ml of blood were added to 50 ml of 
medium. 
The bottles were incubated overnight at 37 C and a loopfull of medium 
2 
was then plated onto trypticase soy agar with 5% citrated bovine blood, 
1 2 MacConkey agar and tergitol 7 agar. Blood agar plates were incubated 
2 both aerobically and anaerobically in a gaspack anaerobic jar. MacConkey 
agar and tergitol 7 agar plates were incubated aerobically only. All 
culture plates were incubated at 37 C for 72 hrs or until growth was ob­
served. 
^Difco Laboratories. Detroit, Michigan, 
p 
Bio Quest, Cockeysville, Maryland. 
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RESULTS 
BVD Virus Infection 
Clinical observations 
Infection of experimental cattle with BVD virus did not produce 
significant clinical disease. Some individual animals showed depression 
and inappetence during the first 2 to 3 days and, occasionally, a mild 
mucous nasal discharge was observed during the same period. No signifi­
cant temperature changes were recorded other than transient elevation to 
103-104 F in three of the calves on the third or fourth days following 
inoculation. 
Hematological changes 
A leukopenic response was observed in all animals following infec­
tion. Low WBCC were present on the first or second day postinoculation, 
and reached the lowest counts on the fourth or fifth day. Figure 1 shows 
the mean WBCC for all calves inoculated with BVD virus in experiments 1 
through 4. The results are expressed as percenlayes uf Llic piciiioculaticn 
mean WBCC (100%). An increase in the number of immunoglobulin-bearing 
lymphocytes was observed on the second day (Figure 2). 
Virus isolation 
Recovery of BVD virus from the blood of BVD inoculated calves was 
inconsistent. Virus was recovered on only five occasions, from blood 
clots taken at 2, 3 or 4 days postinoculation. Viral titers were low 
(2-10 PFU/ml) in all cases. 
Figure 1. Mean responses to phytohemagglutinin-P of peripheral blood lymphocytes during the period 
following inoculation of cuttle with BVD virus. The stimulation was measured by the 
Incorporation of thymidine. The results are expressed as stimulation ratios (cpm of 
PHA stimulated lymphocytes/cpm of unstimulated lymphocytes) in calves infected with BVD 
virus (PHA) and in control calves PHA (C). White blood cell counts (WBCC) are ex­
pressed as percentage deviation from the preinoculation levels (100%). The vertical 
bars and figures in the upper left hand corner represent the percentages of animals 
with positive bacterial blood cultures following BVD virus inoculation. 
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Figure 2. Percentage of immunoglobulin bearing cells in Ficoll-Hypaque 
isolated lymphocytes in the period following BVD virus inocu­
lation. Results are expressed as percentage deviation from 
the preinoculation values (100%). They are the mean values of 
2, 6 or 10 animals as shown in the top portion of the figure. 
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Response of lymphocytes in culture to mitogens following BVD virus 
infection 
The response of lymphocytes to PHA and PWR was greatly reduced fol­
lowing infection. Decreased responses were already apparent the first day 
following inoculation, and lower responses were observed during the second 
and third days. Figures 1 and 3 show mean stimulation ratios (cpm stimu­
lated cells/cpm unstimulated cells) of peripheral blood lymphocytes of 
calves inoculated with BVD virus. It should be noted that although the 
lowest mean stimulation ratios were observed on the third day postinocula-
tion, the lowest cpm recorded corresponded to the second day. The stimu­
lation ratios were lower on the third day due to increased label uptake 
by unstimulated lymphocytes on that day. 
The production of interferon by PHA stimulated lymphocytes was also 
reduced by infection; the mean interferon titer in cultures of lymphocytes 
(mean of five calves) were 128 on inoculation day and 16 on day 3, PHA 
stimulated interferon was susceptible to pH 2 but showed appreciable re­
sistance to treatment at pH 3 (Table 3). 
Observation of bacteremia following BVD virus inoculation 
During some of the preliminary BVD challenge experiments and during 
experiment 1, almost all lymphocyte cultures started on the first few days 
following BVD virus inoculation showed extensive bacterial contamination. 
This repeated observation, and the failure to identify any cell culture 
medium component or the reagents employed in lymphocyte separation as 
possible sources of the contamination, led to consideration of the possi­
bility of bacteremia following BVD infection. Therefore, blood cultures 
in commercial blood culture medium were used to investigate this 
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Figure 3. Mean stimulation ratios of peripheral blood lymphocytes during 
the period following inoculation of cattle with BVD virus. The 
lymphocytes were treated with phytohemagglutinin-P (PHA), poke-
weed mitogen (PWM) or left untreated in culture with stimula­
tion measured by the incorporation of ^M-thymidine. 
68 
Table 3. ' Reduction of interferon activity of samples dialyzed against low 
pH buffer for 24 hrs. Results are expressed as range of the 
percent reductions of the original interferon activity when both 
untreated and treated samples were assayed at the same time 
Supernatant fluid of 
stimulated lymphocyte cultures pH 3 pH 2 
PHA 50-75 100 
I BR 50-75 100 
Serum 25-50 50-75 
possibility on the third day following BVD virus inoculation in experiment 
1 and in most of the other experiments thereafter. The results of these 
cultures are shown in Table 4 and Figure 1. 
Control calves were included in all the experiments starting in ex­
periment 2. They consisted of unino ulated calves or BVD immune calves 
reinoculated with BVD or inoculated with IBR virus. 
The contaminants isolated from lympnocyie cultures in experimeriL 1 
consisted of Pseudomonas spp. that were resistant to all antibiotics 
assayed with the sole exception of gentamicin. 
Bacterial isolates from blood cultures yielded Bacillus spp. in all 
cases, either in pure culture or associated with alpha hemolytic 
Streptococcus spp. in two cases. All the isolates were sensitive to 
gentamicin and of variable sensitivity to other drugs including penicillin 
and streptomycin. The routine inclusion of gentamicin in the lymphocyte 
cultures starting with experiment 2 prevented further problems with cul­
ture contamination. 
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Table 4. Number of animals with positive bacterial blood cultures in the 
period following BVD virus infection 
Days following inoculation 
Experiment Calves 12 3 4 5 6 
1 BVD 4/4* 4/4* 4/4 _b - -
Control - - - - - -
2 BVD 0/3 1/3 1/3 0/3 0/3 -
Control^ 0/3 0/3 0/3 0/3 0/3 -
3 BVD - 2/2 - 2/2 1/2 0/2 
Control^ - 0/ 2 - 0/2 0/2 0/2 
4 BVD - 2/2 - 2/2 - -
Control® - 0/3 - 0/2 - -
6 BVD^ 2/2 2/2 - 1/2 - 0/2 
Control^ 0/2 0/2 - 1/2^ - 1/2^ 
TOTALS BVD 5/9 11/13 5/7 5/9 1/5 0/4 
Control 0/5 0/10 0/3 i/gh 0/5 1/4^ 
^Lymphocyte culture contamination. 
^Not done. 
^Two of the controls were calves reinoculated with BVD virus. The 
third calf was an uninoculated control. 
'^Calves reinoculated with 5VD virus. 
^Uninoculated control calves. 
^Susceptible calves inoculated with BVD and IBR viruses. 
^BVD immune calves inoculated with IBR virus alone. 
"^Positive in medium with SPS only (calf #337). 
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In addition to the control calves included in each experiment, blood 
cultures were made from ten of the calves 18 days and again 60 days after 
the beginning of the last experiment. Results are shown in Table 5. 
Table 5. Number of animals with positive bacterial blood cultures after 
complete recovery from BVD virus infection 
• Days following inoculation^ 
Medium 18 60 
Columbia broth 0/10 0/10 
Columbia broth with SPS 5/10 2/10 
It refers to the date of the start of the last experiment. The four 
calves used in experiment 6 are included here plus six additional calves 
used in prior experiments. 
Nine isolates out of a total of 34 Bacillus spp. were identified as 
Bacillus cereus. Three additional strains were tentatively identified as 
B^ subtil is, two as ^ brevis, one as ^ badius, and four as B^ coagulans 
(Gibson and Gordon, 1974; Cowan eiiiû SLecl, 1S6G). The ram&indcr were net 
identified, and even the total number of species involved is uncertain 
because of the variation in colony morphology^ It was estimated that at 
least eight different species were isolated. 
Production of circulating interferon 
Interferon was detected in the serum of all BVD virus-infected cattle 
during the first 5 days following inoculation. Peak titers were observed 
on day 4 (Figures 4 and 5). Dialysis against pH 2 buffer for 24 hours did 
not destroy ths interferon activity (Table 3), Circulating interferon was 
Figure 4. Mean serum interferon titers (reciprocal of highest dilu­
tion of serum causing 50% or more reduction in the number 
of VSV plaques) in the period following inoculation of 
cattle with I BR or BVD virus. 
Figure 5. Production of interferon in cultures of lymphocytes stimu­
lated with IBR antigen. Results are expressed as mean 
titers of interferon produced by lymphocytes from cattle 
inoculated with IBR virus alone (IBR) or with ÎBR virus 
following BVD virus challenge (BVD-IBR), . 
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not detected in any of the calves reinfected with BVD virus in experiments 
2 and 3. 
Specific immune response 
Figure 6 shows the antibody response to BVD virus. Both complement-
requiring and complement-independent neutralizing antibodies were first 
detected 10 days following challenge and peaked at 24 days. The addition 
of complement resulted in maximum enhancement of neutralization at day 17, 
when the mean complement-requiring antibody titer was more than twofold 
higher than the complement-independent titer. Enhancement by complement 
was not observed after 31 days. Reinoculation of cattle with BVD virus 
resulted in a twofold increase in antibody titers in most cases, but the 
addition of complement did not enhance this neutralizing activity. 
Attempts to stimulate lymphocytes with BVD antigen in vitro were 
unsuccessful. Incubation of lymphocytes collected at different times 
following infection, with varying quantities of BVD antigens (strains 
1015 or NADL), did not result in an increase of thymidine incorporation 
or in immune formation of interferon. 
Development of cytotoxic activity by peripheral blood leukocytes after BVD 
infection 
Lymphocytes from calves recovering from BVD infection exhibited cyto­
toxicity for BVD-coated CRBC as measured by s^Cr release. Figure 7 shows 
the development of this cytotoxic activity expressed as percentage of sicr 
release (percentage of sicr release from CRBC in the presence of lympho­
cytes minus percentage of spontaneous release, i.e., that of CRBC alone). 
The results for experiment 1 were reported separately from the other 
experiments because the process of CRBC-coating was slightly changed in 
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Figure 6. Development of complement-dependent (C) and complement-inde­
pendent (HC) BVD neutralizing antibody in serum of cattle 
following inoculation with BVD virus. Results are expressed 
as mean antibody titers (reciprocal of the highest serum dilu­
tion neutralizing 80% or more of the viral cytopathic effect) 
in a micro-neutralization test. 
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Figure 7. Development of cytotoxic activity in peripheral blood leukocytes of cattle following 
inoculation with BVD virus. Results are expressed cis mean percentages of siQr release 
± standard error from BVD-coated chicken erythrocytes. 
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the latter to reduce the amount of spontaneous release of s^Cr. The 
change, an increase in the amount of antigen, and a decrease in the amount 
of ECDI, apparently decreased the sensitivity of the test. However, the 
modification increased the stability of the cells and reduced the spon­
taneous release of sicr from a variable 15-35% in experiment 1 to a much 
more constant 9-14% in the remainder of the experiments. 
In all experiments, the cytotoxic activity was first observed around 
the seventh day following inoculation and peaked at 10 days. The activity 
decreased thereafter, vanishing 1 to 3 weeks later (Figure 7). This 
activity, however, was not specific; the percentage of siQr release by IBR 
or ERV virus-coated CRBC was essentially the same as that of BVD coated 
cells. The nonspecificity of the reaction prompted an attempt to identify 
the effector cells. Passage of the Ficoll-Hypaque separated lymphocytes 
throuth cotton or nylon wool columns resulted in either complete removal 
or marked reduction oT the cytotoxic activity. The resulting cell sus­
pensions were composed almost entirely of small lymphocytes with essen­
tially no iiiacrophaye-like cells aiiu a reduction in the nun,bar of immur.c 
globulin-bearing cells. 
Fractionation of the cells into plastic adherent and nonadherent 
populations resulted in limited activity associated with the latter, but 
marked activity associated with many of the adherent cell populations. 
This increase was not constant, however, mainly due to clumping during 
washing of some of the adherent cell preparations. 
Table 6 shows mean activity of the different cell populations from 
five different calves at 7, 11 and 14 days postinoculation. 
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Table 6. Cytotoxic activity of peripheral blood leukocytes from calves 
inoculated with BVD virus. Identification of effector cells 
Cell populations 
Days post- Ficoll- Nylon Nonad­
inoculation Hypaque Cotton Wool herent Adherent 
7 1.90* 0.00 0.30 0.86 5.93 
11 11.38 2.95 1.86 2.55 3.93 
14 6.94 2.03 0.73 3.10 8.83 
Percentage of sicr release {% siCr release in the presence of leuko­
cytes - % spontaneous sicr release by CRBC alone). Means of five calves, 
target cells: BVD-coated CRBC. 
IBR Virus Infection 
Clinical observations 
Clinical signs in IBR infected calves were usually confined to nasal 
and ocular discharges. Mucous discharges were first observed on the 
second day after inoculation, later became mucopurulent in character and 
persisted for at least 6 to 10 days. There was a tendency for either 
larger quantities of discharges, or more persistent discharges, or both, 
in calves infected with IBR virus following BVD virus infection; the dif­
ference became evident after the fourth or fifth days following IBR virus 
infection, at a time when the discharges started to decrease in calves 
infected with IBR virus alone. 
Elevations in body temperature were not a constant feature, but four 
of the eight calves had increased rectal temperatures (103 F or higher) 
on day 3 and 4 following IBR virus inoculation. Mean temperature readings 
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were approximately the same for calves infected with IBR virus alone or 
BVD virus followed by IBR virus infection. 
Hematological changes 
Total WBCC and B cell counts did not significantly change following 
IBR virus infection. The changes observed in calves infected with both 
viruses were similar to those induced by BVD virus alone. 
Virus isolation 
IBR virus was repeatedly isolated from nasal secretions during more 
than 2 weeks following initial infection. Table 7 shows a detail of the 
virus shedding by all eight calves. A more prolonged excretion was ob­
served in the calves infected with both BVD and IBR viruses. 
Response of lymphocytes in culture ^ mitogens following IBR virus infec­
tion 
The response of lymphocytes to PHA and PWM were essentially normal 
following IBR virus infection. Responses to PHA and PWM in calves in­
fected with both BVD and IBR viruses followed essentially the same pattern 
as in calves inutuldlcu with SVD viriis alcr.s. 
Production of circulating interferon 
Peak interferon activity was detected in the serum of IBR infected 
calves on day 3 after infection (Figure 4) and persisted at decreasing 
levels until day 9 in some of the calves. No differences in serum inter­
feron titers were observed between calves infected with either IBR virus 
alone or the combined BVD-IBR virus infection. 
Specific iirenune responses 
Figure 8 shows the temporal development of antibody to IBR virus. 
Neutralizing antibody was first produced between 6 and 9 days post-
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Table 7. Isolation of IBR virus from nasal secretions following infection 
of cattle with IBR virus alone or with IBR virus 2 days after 
challenge with BVD virus 
Days following IBR virus infection 
Animal 4 6 9 11 15 18 30 
IBR* 
330 + + _c - ND^ ND 
331 + + + + ND ND 
335 + + - - - - -
337 + + + + - - + 
BVD-IBR® 
333 + + + + + ND ND 
347 + + + + + ND ND 
341 + + + + + + -
NT + + + - + + -
^Calves infected with IBR virus alone. 
'^Positive isolation. IBR virus identified by FA test. 
^Negative. 
"Not done. 
®Calves infected with IBR virus 2 days after challenge with BVD 
virus. 
inoculation, reached peak titers on day 17, and decreased thereafter. 
Complement greatly increased the neutralizing activity of serum during the 
first 3 weeks following infection. Maximum differences between mean 
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Figure 8. Development of complement-dependent (C) and complement-inde­
pendent (HC) IBR neutralizing antibody in serum of cattle 
following inoculation with IBR virus. Results are expressed as 
mean antibody titers (reciprocal of the highest dilution of 
serum neutralizing 80% or more of the viral cytopathic effect) 
in a micro-neutralization test. 
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titers of complement-dependent and independent antibody were observed on 
day 17. 
Mean antibody titers to IBR virus were significantly higher in calves 
that received the combined BVD-IBR exposure than in calves infected with 
IBR virus alone (Figures 9 and 10). The mean peak antibody titers on day 
17 following IBR virus infection were 168 (complement-dependent) and 34 
(complement-independent) in calves infected with both BVD and IBR viruses, 
as compared to 50 (complement-dependent) and 12 (complement-independent) 
in calves infected with IBR virus alone. 
In vitro lymphocyte stimulation by IBR virus was first observed on 
day 5 following IBR virus infection; responses peaked at day 6, and 
dropped to almost background levels between days 11 and 16 (Figure 11). 
When the calves were infected 2 days earlier with BVD virus, however, 
there was a delay in the appearance of the peak stimulatory activity until 
after day 6. When the mean stimulation ratios of the two groups were com­
pared, they were significantly different on day 6 (student's t test, 
n .A m \ n\ 
Similar differences were observed in the production of interferon by 
antigen stimulated lymphocytes; iiraiune production of interferon by lympho­
cyte cultures from calves infected with IBR virus alone was first observed 
at day 5. No interferon was detected in lymphocyte cultures from BVD-IBR 
virus infected calves on that day, and the mean interferon titer on day 6 
was only one-fourth of the mean titer in calves infected with IBR virus 
alone (Figure 5). The interferon produced by antigen stimulated lympho­
cytes was completely sensitive to pH 2 (Table 3) but showed appreciable 
stability at pH 3. 
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Figure 9. Complement-independent IBR neutralizing antibody in serum of 
cattle inoculated with IBR virus alone (IBR) or with IBR virus 
2 days after challenge with BVD virus (BVD-IBR). 
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Figure 10. Complement-dependent IBR neutralizing antibody in serum of 
cattle inoculated with IBR virus alone (IBR) or with IBR virus 
virus 2 days after challenge with BVD virus (BVD-IBR). 
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Figure 11. Lymphocyte stimulation by IBR antigen in the period following 
inoculation of cattle with IBR virus alone (IBR) or IBR virus 
2 days after challenge with BVD virus (BVD-IBR). The stimula­
tion was measured by the incorporation of ^H-thymidine. Re­
sults are expressed as mean stimulation ratios (cpm in IBR 
stimulated lymphocytes/cpm in unstimulated lymphocytes). 
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Development of cytotoxic activity jhi peripheral blood leukocytes after IBR 
virus infection 
Cytotoxic activity also developed after IBR virus infection. Figure 
12 shows percentage of sicr release from IBR-coated CRBC incubated with 
lymphocytes collected from calves infected with IBR virus alone or BVD and 
IBR viruses. The activity was in general lower than that observed after 
BVD virus infections, but it was specific initially in calves infected 
with IBR virus alone. 
Table 8 shows the cytotoxic activity of lymphocytes collected at 6, 9 
and 11 days postinoculation against IBR-, BVD- or rhinopneumonitis virus-
coated CRBC. The activity was entirely specific on day 6, and still 
specific in three of the calves on day 9, although all calves showed non­
specific cytotoxicity by day 11. The cytotoxic activity of lymphocytes 
from those calves infected with both viruses was nonspecific at all times. 
The early (day 6) cytotoxic activity was largely retained after 
cotton filtration of lymphocytes from calves Infected with IBR virus 
aione; the nonadhereni cen population rstainsd full cytotoxic activity in 
one-half of the cases. At this time essentially no activity could be 
demonstrated with adherent cells (Table 9). 
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Figure 12. Development of cytotoxic activity in peripheral blood leuko­
cytes of cattle following inoculation with IBR virus alone 
(IBR) or with IBR virus 2 days after challenge with BVD virus 
(BVD-IBR). Results are expressed as mean percentages of sicr 
release ± standard error from IBR-coated chicken erythrocytes. 
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Table 8. Specificity of the cytotoxic activity of peripheral blood leuko­
cytes from cattle inoculated with IBR virus 
Animal 
6 DPI* 9 DPI 11 DPI 
IBR BVD ERV IBR BVD ERV IBR BVD ERV 
IBR^ 
330 3.5C 0.8 0.6 6.0 7.8 6.5 1.1 1.7 1.3 
331 2.8 0.0 0.0 1.0 0.0 0.2 3.5 1.0 1.2 
335 0.9 0.0 0.0 1.2 0.0 0.0 9.9 3.4 1.9 
337 1.9 0.0 0.0 1.8 0.0 0.0 4.8 5.4 3.7 
BVO-IBR^ 
333 8.5 5.3 6.2 
CO 0
0
 
1.5 1.9 8.5 5.7 8.2 
347 14.8 9.8 9.6 3.6 2.9 2.4 5.5 3.2 0.9 
341 2.1 2.6 1.8 2.0 1.9 0.9 1.5 0.8 0.4 
NT 3.0 3.3 2.6 3.1 3.3 1.3 0.8 1.2 0.7 
®Days postinoculation. 
"C2:ves infected yith IBR Hlnnê. 
Percentage of sicr release (% s^Cr release in the presence of leuko­
cytes - % spontaneous s^Cr release by CRBC alone). Target cells: CRBC 
coated with IBR, BVD or ERV antigens. 
^Calves infected with IBR virus 2 days after challenge with BVD 
virus. 
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Table 9. Cytotoxic activity of peripheral blood leukocytes on day 6 
following inoculation with IBR virus. Identification of 
effector eel1 s 
Cell populations 
Animal Ficoll-Hypaque Cotton Nonadherent Adherent 
330 3.5* 2.9 3.0 0.5 
331 2.8 1.4 4.2 0.0 
335 0.8 0.5 0.0 0.0 
337 1.9 1.1 0.0 0.0 
Percentage of sirr release (% ®^Cr release in the presence of leuko­
cytes - % spontaneous s^Cr release by CRBC alone). Target cells: IBR-
coated CRBC. 
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DISCUSSION 
Recovery from Infection 
Most of the studies on immunologic responses to viral infections have 
largely assessed the significance of these responses in terms of resist­
ance to reinfection but less attention has been paid to the role of the 
immunologic response in recovery from primary viral infections. The 
coincidence in time between recovery and appearance of nonspecific defense 
mechanisms, cell-mediated immunity or circulating antibody provides some 
indication of the nature of the mechanism promoting recovery. Attempts at 
passive protection of the animal by providing antiviral factors is another 
possible approach to the study of recovery. It is likely that the host 
defenses will play different roles in recovery from various viral infec­
tions and, in order to assess the effectiveness of the various antiviral 
factors, temporal and spatial considerations are important. 
The present study has shown that circulating interferon appears early 
in response to BVD virus infection, Jiid it could play an rnlw in 
recovery. Baron (1970; 1973) has pointed out that interferon, because of 
its early appearance^ is an important part of the body's nonspecific re­
actions, probably one of the major contributors to recovery from many 
established viral infections. Circulating interferon is almost always 
induced by viruses capable of producing viremia (Baron et al., 1966a). 
When passively transferred interferon or noninfective interferon inducers 
are injected shortly before infectious virus, the spread of the virus from 
blood to target organs is impaired and the survival rates of injected 
animals are increased (Baron et al., 1966b; Pinter, 1973). 
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Assessment of the relative role of defense mechanisms in recovery 
from BVD infections presents a major problem because of the difficulty in 
experimental production of clinical disease with obvious signs of illness 
and the sparsity of positive virus isolations. In this study, however, 
lymphocyte responsiveness to mitogens and total WBCC following infection 
could be considered as indicators of recovery. Therefore, the temporal 
relationship between appearance of the different defense mechanisms and 
the return to normality of these functions can be established. Circu­
lating interferon was already present 24 hrs after infection and the titer 
peaked at day 4. Lymphocyte responses to PHA and PWM were minimal on day 
3, but active responses were evident on day 4. The lowest blood leukocyte 
counts were recorded on days 4 and 5 but rising counts were evident by day 
7. Furthermore, the bacteremia observed after BVD infection, as will be 
discussed later, was clearly declining on days 4 and 5, and nonexistent 
by day 6. In comparison, neutralizing antibody, a measure of the specific 
immunologic response, was not detected until after day 7. These observa­
tions clearly suggest a pruLeuLivc role for intcrferoû. Or. the ether 
hand, interferon was not detected after reinoculation of BVD virus into 
"immune" animals, a situation in which the protective role of circulating 
antibody is evident. Prior specific immunity is perhaps one possible 
explanation for Rosenquist's failure (Rosenquist, 1973) to detect inter­
feron production in most calves infected with BVD virus. 
Although the appearance of circulating antibody may not account for 
functional recovery of the infected calves, specific antibodies very 
likely play a role in the elimination of the virus and termination of the 
infection. In particular, the early complement-requiring antibody 
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response might suggest that complement fixing antibody could play a role 
in destruction of infected cells. This is substantiated by the observa­
tion that BVD virus-infected cells are susceptible to lysis by antiviral 
antibody and complement (Ritchie and Fernelius, 1969). 
The failure to detect any evidence of a cell-mediated iimune response 
agrees with previous reports on the ability of BVD virus to replicate in 
"immune" lymphocytes (Truitt and Shechmeister, 1973). It also agrees with 
unpublished observations at the University of Minnesota (C. Muscoplatt, 
personal communication) in which there was a failure to demonstrate any 
significant degree of stimulation by BVD antigens of lymphocytes from 
calves recovering from BVD virus infections. The possibility of "toxic" 
or otherwise inadequate antigens cannot be excluded, however. Indeed, 
Graziano et al. (1975) reported successful lymphocyte blastogenesis by 
measles complement fixation antigen despite earlier negative reports where 
different antigen preparations were employed. 
A most intriguing observation in the present study was the develop­
ment of nonspecific cytotoxic activily nieuiaUu L.y peripharcl bleed Icukc-
cytes following BVD virus infection. Attempts to locate the activity in 
association with different cell populations clearly identified the plastic-
adherent macrophages as the cy1;otoxic cells. The increased "killer" 
function of macrophages in response to infection is one of the main char­
acteristics of the "activated" macrophage usually associated with recovery 
from bacterial infection (North, 1974; Nelson, 1972). Evidence is accumu­
lating however for a similar role of macrophages in response to viral in­
factions. Blander (1970» 1971a; 1971b) demonstrated that macrophages play 
a major role in recovery from sctrcmslia virus infection in mice. Blanden 
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and Mims (1973) demonstrated macrophage activation 8 days following infec­
tion with ectromelia or lymphocytic choriomeningitis virus in mice. 
Pathak et al. (1974) reported activated macrophages with antiviral and 
antibacterial properties following infection of chickens with fowl pox 
vi rus. 
The general consensus is that macrophage activation occurs following 
a cell-mediated immunologic response (Mackaness, 1971; Nelson, 1972; 
North, 1974), but such a reaction was not demonstrated during BVD infec­
tion. Although this failure could be accounted for by inadequate experi­
mental techniques, it is important to bear in mind that there were dif­
ferences in the cytotoxic activity observed following BVD and I BR virus 
infections. The former was completely nonspecific at all times and 
mediated by adherent cells. The latter was specific initially and medi­
ated by nonadherent cells. This suggests that macrophage activation did 
not follow lymphocyte sensitization but was evoked by a different mecha­
nism. 
Otîiêr reports ir.dicatG that ccll-ssdiated immunity may nnf. hA thé 
sole means by which macrophages are inactivated. Takeya et al. (1968) 
observed activated macrophages in neonatally thymectomized mice, and 
Blanden and Langman (reported by Blanden and Mims, 1973) made a similar 
observation in adult mice, thymectomized as adults, lethal ly irradiated 
and reconstituted with isogeneic bone marrow. These animals had a greatly 
depressed capacity for a cell-mediated immunologic response. Although an 
alternate mechanism of macrophage activation is unknown, Alexander and 
Evans (1971) reported activation of macrophages, both in vivo and in 
vitro, by viral double stranded RNA. North (1974) observed a great 
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increase in macrophage spreading in vitro after binding of antibody on the 
macrophage membrane. Both mechanisms, if these observations can be con­
firmed and extended to viral infection in vivo> may offer a basis for the 
understanding of mechanisms of macrophage activation in the absence of a 
cell-mediated immunologic response. Although normal macrophages are able 
to attach to chemically treated erythrocytes (Rabinovitch, 1970), evidence 
from the experiments would definitely indicate that there was activation 
of plastic adherent cells. Indeed this is not unlikely since the bac­
teremia associated with BVD virus infection could have been a contributing 
factor to the activation process. 
Whatever the mechanism of activation, the role of macrophages in re­
covery, if any, is unknown. Their activity was first recorded 7 days 
post-BVD virus infection when recovery was completed. However, activated 
macrophages may have been active in the animals long before in vitro 
cytotoxicity was detected since in vitro cytotoxic assays may not be ade­
quately sensitive to detect low level in vivo macrophage activity. In any 
event, activated macrophages have been reported to be essential in the 
destruction of viral "foci" in ectromelia virus-infected mice (Blandens 
1971b) , and presumably they collaborated in the elimination of the BVD 
virus infection in my experimental cattle. 
The IBR virus infection was essentially localized to the respiratory 
tract, both from the clinical and the virological standpoints, since 
viremia was not detected at any time. No attempt was made in this study 
to evaluate local defense mechanisms and therefore any conclusion on 
mechanisms of recovery from the infection must be based solely on observa­
tions on generalized immunologic responses and reports in the literature. 
Circulating interferon was the first observed response with peak 
activity occurring on day 3, at least 2 days before specific immunologic 
responses were observed. Interferon is usually produced locally after 
intranasal IBR infection (Todd, 1973) and, in view of the relatively high 
titers of serum interferon detected, we can assume that such a response 
occurred in the present study as well. Although local production could be 
important in protection of susceptible cells, the function of circulating 
interferon, other than as a possible indicator of local reactions, remains 
largely a matter of conjecture. If we accept serum interferon as a re­
flection of local production, we must conclude that interferon, although 
of possible defensive value early in the disease process, was not a major 
factor in clinical recovery from IBR virus infection. This conclusion is 
based on the observation that calves infected with IBR virus alone, or 
with both BVD and IBR viruses, produced essentially identical levels of 
circulating interferon. Furthermore, calves previously infected with BVD 
virus showed more prolonged virus excretion and more severe mucosal dis­
charges following IBR infection which would indicate a failure OT bvu 
produced interferon to provide protection. 
The specific immunologic response to IBR virus appeared later than 
interferon in the process of infection. Cell-mediated immunologic re­
sponses were first detected on day 5 following infection. The lymphocyte 
blastogenic response peaked between days 6 and 9. Although the response 
was limited, its temporal development paralleled the specific lymphocyte 
transformation pattern reported by Rouse and Babiuk (1974a) following 
intranasal infection of calves with IBR virus. The minimal responses 
could be due to the lack of purification of the antigen used in this 
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study, to the age of the experimental animals, or both. Age differences 
are particularly important since very young calves were used in the pre­
vious reports. 
The production of "immune" interferon in vitro by stimulatej lympho­
cytes was first detected at day 5 and remained high for several days, with 
the highest mean titer recorded on day 11. The "inrnune" character of the 
interferon produced by lymphocytes was concluded from its total suscepti­
bility to pH 2 treatment although still conserving significant activity 
after dialysis at pH 3, in agreement with previous renorts (Falcoff, 
1972). The more prolonged production of "immune" interferon as compared 
with lymphocyte transformation responses is in agreement with a previous 
report on lack of correlation between these responses by human lymphocytes 
stimulated with vaccinia virus antigen (Epstein et al., 1972). 
The antibody response to IBR virus was detected later than the sixth 
day following infection. The bulk of this early antibody response was 
composed of complement-dependent neutralizing antibody, as already re-
purLeu by Rossi âiiu Kiesel (1374) and Pctglctcr (Î975}. Humoral antibo^y 
is not likely to have been an important factor in the initial events of 
recovery due to its late appearance, and because the higher titers were 
actually present in the calves infected with both BVD and IBR viruses 
where recovery was slower. 
The cell-mediated immunologic response on the other hand, was the 
only defense mechanism significantly impaired in this group of calves, 
where a delay in the peak responses, or overall lower responses were ob­
served. Rouse and Babiuk (1974a,b) and Davies and Carmichael (1973) have 
already suggested a major role for cell-mediated reactions in recovery 
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from ÎBR infection. They based their conclusions on time of appearance of 
the reaction as compared to clinical recovery and analogy with other 
herpes viruses known to spread from cell to cell through intercellular 
bridges (Christian and Ludovici, 1971) before antibody plus complement can 
lyse infected cells (Lodmell et al., 1973). The present observation of 
correlation between delayed cell-mediated responses and prolonged recovery 
lends strong support to that view. 
The unexpected observation of much higher antibody titers, and espe­
cially complement fixing antibody, in those calves preinfected with BVD 
virus raises the possibility of antibody-mediated cell lysis as an immuno-
pathological mechanism hindering recovery (Notkins, 1971). This possi­
bility cannot be seriously considered, however, without actual determina­
tion of antibody levels in respiratory secretions since different immuno­
globulin classes are involved in the local responses of cattle to respira­
tory viruses (Porter, 1973; Todd, 1973), Furthermore, although increased 
antibody response at the local level could account for more extensive cell 
destruction, a more proloiiyeû vit us excrétiori is difficult tc expiai: 
since free virus should be rapidly neutralized (Lodmell et al.» 1973). 
The cytotoxic activity in the peripheral blood lymphocytes was first 
detected on day 6 following IBR infection. The initial specific activity 
associated with nonadherent small lymphocytes, is undoubtedly part of the 
cell-mediated immunologic response and very likely has an important role 
in recovery by destroying virus-infected cells (Rouse and Babiuk, 1974b; 
Lodmell et al., 1973). The increasing nonspecificity of the reaction with 
time after infection suggests the participation of activated macrophages. 
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Although the mechanism of activation is unknown, specifically stimulated 
lymphocytes could have been at least partially responsible (Blanden and 
Mims, 1973). 
The role of these activated macrophages in recovery from ÎBR virus 
infection is unknown. They appeared rather late (9 days) in calves in­
fected with IBR virus alone. However, nonspecific cytotoxicity was al­
ready apparent at day 6 in calves previously infected with BVD virus and 
these calves were slower to recover. This observation apparently argues 
against a protective role of activated macrophages, although a clear 
answer to this problem is not possible from the findings of the present 
study. However, a possible role in resistance to reinfection by other 
viruses cannot be ruled out. During the course of the preliminary experi­
mentation conducted prior to research reported in this dissertation, 
attempts were made to infect calves from the Veterinary Medical Research 
Institute with I BR virus. These calves were completely refractory to the 
virus. They had been inoculated with respiratory syncytial virus 4-5 
weeks previously and, although no other parameters of nonspccific resist­
ance were investigated, it was observed that all of them exhibited sub­
stantial degrees of cytotoxic activity associated with blood leukocytes 
prior to the IBR virus challenge. Similar nonspecific cytotoxic activity 
was found in blood leukocytes of several cattle brought to the Department 
of Veterinary Clinical Sciences for treatment of different clinical con­
ditions and where exposure to infectious agents is very likely. These 
observations are obviously inconclusive, but it is very tempting to specu­
late that macrophage activation could be a common reaction of cattle to 
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infection and that such cells, at least in the case of IBR virus, could 
play a role in resistance to infection. 
Effect of BVD Virus Infection on the Immune System 
Despite the repeated observation of BVD virus involvement in multi­
ple-etiology disease conditions, the only experimental evidence for a 
possible iimiunosuppressive effect has come from indirect studies. Truitt 
and Shechmevster (1973) reported that BVD virus can infect both macro­
phages and lymphocytes under in vitro conditions. Muscoplatt et al. 
(1973a) observed inhibition of lymphocyte responses to PHA after in vitro 
infection or during the course of experimental disease. 
The present study has confirmed some of these results such as the 
observation of a sharp reduction in lymphocyte responsiveness to PHA and 
PWM during the first 3 or 4 days following infection. PHA responses are 
usually not dependent on macrophage function (Waldron et al., 1973) and 
therefore BVD virus must act by a direct inhibitory effect on T lympho­
cytes . 
At! increase in the ûuabcr of ccVls surface inwiynncjinhiilin was 
also observed particularly on day 2 following infection. This increase 
was most likely a relative one due to a decrease in other cell popula­
tions, but became less pronounced as the total number of white cells de­
creased. This could be interpreted as a preferential or more dramatic 
effect of the virus on the nonimmunoglobulin bearing cells, thereby im­
plying the possibility of a relative resistance of B cells to the leuko­
penic effects of infection. Reports of alteration in Immunoglobulin 
synthesis in chronic BVD infection (Muscoplatt et al., 1973b) as evidenced 
by a decreased number of circulating B lymphocytes or lack of antibody 
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response to BVD virus are somewhat contradictory with the present work. 
However, the depressed antibody response in chronic BVD infections could 
be a cause rather than a consequence of the infection. There is no evi­
dence to support a primary viral etiology and the possibility of a primary 
immunodeficiency has not been investigated (Malmquist, 1968; Bittle and 
House, 1973), 
The more direct evidence for an immunosuppressive effect came from 
the observation of bacteremia and the study of the immunologic response to 
I BR virus. The occurrence of positive blood cultures in up to 85% of in­
fected calves, with consistently negative cultures from control or re-
inoculated "immune" calves, is a strong indication of a causal relation­
ship between BVD infection and bacteremia. It clearly indicates a nega­
tive effect of infection on normal defense mechanisms and, more particu­
larly, the blood clearance function associated with tissue and circulating 
macrophages (Raffel, 1951). 
The positive cultures from normal calves recorded when medium with 
SHb was used indicates that bacteremia is of cunmiun uLcurrenCc in cattle. 
The use of BPS, known to be anticomplementary and to inhibit the normal 
bactericidal action of blood and the phagocytic activity of leukocytes 
(Ellner and Stoessel, 1966), apparently allowed the isolation of bacteria 
normally inhibited when regular blood culture medium was used. A concept 
of "normal" bacteria in the circulation of cattle should not be sur­
prising. In man, commensal microorganisms from the normal flora of the 
mouth, nasopharynx and intestines can be carried from time to time into 
the blood where they are normally promptly phagocytized (Joklik and Smith, 
1972). In cattle, pathogenic microorganisms, and more notably CI. chauovei 
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and Cl. novyi, are known to invade the body through enterohepatic circula­
tion and can be isolated from normal livers or spleens (Smith and 
Holdeman, 1968). 
The uninhibited presence of bacteria in blood during infection would 
be best explained by multiplication of the virus in macrophages with re­
sultant cell death or functional impairment. Probably a variety of bac­
terial organisms were present in the blood of the animals but the almost 
exclusive isolation of Bacillus spp. was a reflection of the experimental 
procedures; these microorganisms could have inhibited the growth of other 
bacteria because of rapid multiplication with resulting competition or by 
production of antibiotics (Korzybski et al., 1967). 
Bacillus cereus, repeatedly isolated from infected or normal calves 
in this experiment, has been incriminated in bovine abortions (Wohlgemuth 
et al., 1972a). Small doses of the organism, when given i.v. to pregnant 
cows, were apparently cleared from the blood before fetal infection 
occurred; large doses were necessary to overcome the reticuloendothelial 
system (Wohlgemuth et al,, 1972b;. BVD viriis infectiGr. could be ens 
possible mechanism to facilitate placental colonization by Bacillus 
C6r6U5. 
Macrophages are also an important nonspecific mechanism of defense 
against some viral infections (Mims, 1964). It is possible that if this 
bacteremia was actually due to a suppression of macrophage function, this 
alteration could have been an important factor in the prolonged recovery 
from I BR infection in experiments 5 and 6. The present study does not 
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offer an answer to this question since no evaluation was made of macro­
phage function in the respiratory tract where the I BR virus infection was 
localized. 
The almost complete inhibition of lymphocyte responses to T cell 
mitogens during the leukopenic phase of BVD infection suggests that T cell 
functions were impaired during infection. T cell function is specifically 
altered in a number of other viral infections including measles 
(McFarland, 1974b), influenza (Kantzler et al., 1974), lactic dehydrogenase 
virus (Howard et al., 1969) and lymphocytic choriomeningitis virus (Bro-
JfSrgensen et al., 1975). Temporary suppression of T cell function by BVD 
virus is a likely mechanism for the delayed cell-mediated responses to IBR 
virus. The mechanism is unknown, but BVD virus replication in T lympho­
cytes could result in death, functional alteration or reduced expansion of 
a specific population of T cells. Loss of T cell function could also 
implicate loss of the normal regulatory functions of T cells in antibody 
production (Gershon, 1974; Katz and Benacerraff, 1972; Baker et al., 1974) 
uiierKU_y yruv i u i iiy a iiicviian i siii lui une mt^icaocu unuiuuujr i ut mu >< • un . 
Alternatively, the mechanism of immunosuppression could reside in a 
loss of macrophage function, Soontiè'ns and Van der Veen (1973) observed 
that the inhibition of PHA responses in human lymphocyte cultures infected 
with poliovirus is due to a direct action on the macrophages. According 
to Hall and Kantor (1972) the depression of pre-existing delayed hyper­
sensitivity during mumps virus infection is due to an inhibition of the 
nonspecific mononuclear effector cells. However, adherent cells are 
necessary for optimal antibody production to complex antigens ( Greaves 
et al., 1973) and the idea of an altered macrophage function would be 
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difficult to conciliate with increased antibody production. Furthermore, 
even if BVD virus inhibits tissue and circulating macrophages as suggested 
by the appearance of bacteremia, there is no conclusive proof that the 
adherent cells involved in the induction of immunologic response are 
phagocytic macrophages (Nelson, 1972). At least in the immunologic re­
sponse of mouse spleen cultures to erythrocyte antigens, there is evidence 
now that the macrophages that digest the particulate antigens are distinct 
from the adherent cells required to deliver the inductive stimulus to pre­
cursor antibody-forming cells or to thymus-derived helper cells (Watson 
et al., 1974). 
The reason for a preferential action of BVD virus on T lymphocytes, 
with minor or no effects on B lymphocytes, is not clear. Woodruff and 
Woodruff (1974) have reported the presence in mouse T lymphocytes of 
specific receptors for several myxo- and paramyxoviruses such as in­
fluenza, Newcastle and Sendai viruses which are known to cause lymphopenia 
or to alter blastogenic transformation of lymphocytes. Whether or not 
similar receptors exist in taille, or even their sigr.lficsr.cc ir. viral 
immunosuppression, is unknown. 
In conclusion, BVD virus seems to exert an immunosuppressive effect 
by action at two levels: (1) nonspecific defense mechanisms, presumably 
the phagocytic cells; and (2) the specific cell-mediated immunologic re­
sponses by interfering with T cell function. Such a combination of 
effects is potentially very significant in the pathogenesis of many viral 
or bacterial infections, and may explain a role for BVD virus infection in 
multiple etiology syndromes of cattle. 
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SUMMARY 
Specific and nonspecific mechanisms of recovery from viral infection 
were studied in feeder calves after intravenous challenge with BVD virus, 
intranasal challenge with IBR virus or a combination of both viruses. 
BVD virus infection resulted in inhibition of the normal blood 
clearance mechanisms as evidenced by the detection of an endogenous bac­
teremia in up to 85% of infected calves on the first 5 days following in­
fection. The responses of lymphocytes in culture to PHA and PWM were 
drastically reduced on the first 4 days following inoculation. Relative 
increases in the number of peripheral blood 3-lymphocytes during the 
leukopenic phase of the disease suggested a preferential action of the 
virus on T lymphocytes. Circulating interferon was consistently de­
tectable after BVD virus infection. Peak titers occurred at the same time 
that responses to mitogens, white blood cell counts and blood clearance 
mechanisms started to regain pre-inoculation levels. Antibody production 
was not detected prior to the eighth day following infection, when all the 
above functions had returned to normal. No specific cell-mediated immu­
nologic responses were elicited by BVD virus infection. 
BVD virus infection 2 days before IBR virus challenge resulted in a 
delayed recovery from IBR infection as evidenced by a more protracted 
clinical condition and a more prolonged period of virus excretiorî. The 
production of circulating interferon was not affected and the titers of 
antibody to IBR virus were increased after BVD virus infection. In con­
trast, cell-mediated immunologic responses to IBR virus, as measured by 
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specific lymphocyte transformation and production of interferon by antigen 
stimulated lymphocytes, were significantly delayed. 
It was concluded that, while circulating interferon may have played a 
major role in recovery from BVD virus infection, cell-mediated immunologic 
responses correlated much more closely with clinical recovery from IBR 
virus infection. 
An immunosuppressive role of BVD virus infection was demonstrated. 
The effects of the virus were apparently exerted on at least two mecha­
nisms, normal blood clearance mechanisms and T-cell function. 
Macrophage activation was demonstrated after infection by both 
viruses with the appearance of cytotoxic activity mediated by peripheral 
blood leukocytes. Plastic adherent cells nonspecifically lysed chicken 
erythrocytes coated with viral antigens. 
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